<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plospath</journal-id><journal-title-group>
<journal-title>PLoS Pathogens</journal-title></journal-title-group>
<issn pub-type="ppub">1553-7366</issn>
<issn pub-type="epub">1553-7374</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PPATHOGENS-D-14-00087</article-id>
<article-id pub-id-type="doi">10.1371/journal.ppat.1004215</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject></subj-group><subj-group><subject>Microbiology</subject></subj-group></subj-group></article-categories>
<title-group>
<article-title>Distinct Lipid A Moieties Contribute to Pathogen-Induced Site-Specific Vascular Inflammation</article-title>
<alt-title alt-title-type="running-head">Modified Lipid A Exacerbates Vascular Inflammation</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Slocum</surname><given-names>Connie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Coats</surname><given-names>Stephen R.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hua</surname><given-names>Ning</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kramer</surname><given-names>Carolyn</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Papadopoulos</surname><given-names>George</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Weinberg</surname><given-names>Ellen O.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gudino</surname><given-names>Cynthia V.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hamilton</surname><given-names>James A.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Darveau</surname><given-names>Richard P.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Genco</surname><given-names>Caroline A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston, Massachusetts, United States of America</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Periodontics, School of Dentistry, University of Washington, Seattle, Washington, United States of America</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Department of Biophysics, Boston University School of Medicine, Boston, Massachusetts, United States of America</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Gunn</surname><given-names>John S.</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>The Ohio State University, United States of America</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">cgenco@bu.edu</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: CS CAG. Performed the experiments: CS NH CK GP EOW CVG. Analyzed the data: CS NH GP CVG. Contributed reagents/materials/analysis tools: SRC JAH RPD CAG. Wrote the paper: CS SRC RPD CAG.</p></fn>
</author-notes>
<pub-date pub-type="collection"><month>7</month><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>10</day><month>7</month><year>2014</year></pub-date>
<volume>10</volume>
<issue>7</issue>
<elocation-id>e1004215</elocation-id>
<history>
<date date-type="received"><day>10</day><month>1</month><year>2014</year></date>
<date date-type="accepted"><day>16</day><month>5</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Slocum et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>Several successful pathogens have evolved mechanisms to evade host defense, resulting in the establishment of persistent and chronic infections. One such pathogen, <italic>Porphyromonas gingivalis</italic>, induces chronic low-grade inflammation associated with local inflammatory bone loss and systemic inflammation manifested as atherosclerosis. <italic>P. gingivalis</italic> expresses an atypical lipopolysaccharide (LPS) structure containing heterogeneous lipid A species, that exhibit Toll-like receptor-4 (TLR4) agonist or antagonist activity, or are non-activating at TLR4. In this study, we utilized a series of <italic>P. gingivalis</italic> lipid A mutants to demonstrate that antagonistic lipid A structures enable the pathogen to evade TLR4-mediated bactericidal activity in macrophages resulting in systemic inflammation. Production of antagonistic lipid A was associated with the induction of low levels of TLR4-dependent proinflammatory mediators, failed activation of the inflammasome and increased bacterial survival in macrophages. Oral infection of ApoE<sup>−/−</sup> mice with the <italic>P. gingivalis</italic> strain expressing antagonistic lipid A resulted in vascular inflammation, macrophage accumulation and atherosclerosis progression. In contrast, a <italic>P. gingivalis</italic> strain producing exclusively agonistic lipid A augmented levels of proinflammatory mediators and activated the inflammasome in a caspase-11-dependent manner, resulting in host cell lysis and decreased bacterial survival. ApoE<sup>−/−</sup> mice infected with this strain exhibited diminished vascular inflammation, macrophage accumulation, and atherosclerosis progression. Notably, the ability of <italic>P. gingivalis</italic> to induce local inflammatory bone loss was independent of lipid A expression, indicative of distinct mechanisms for induction of local versus systemic inflammation by this pathogen. Collectively, our results point to a pivotal role for activation of the non-canonical inflammasome in <italic>P. gingivalis</italic> infection and demonstrate that <italic>P. gingivalis</italic> evades immune detection at TLR4 facilitating chronic inflammation in the vasculature. These studies support the emerging concept that pathogen-mediated chronic inflammatory disorders result from specific pathogen-mediated evasion strategies resulting in low-grade chronic inflammation.</p>
</abstract>
<abstract abstract-type="summary"><title>Author Summary</title>
<p>Several human pathogens express structurally divergent forms of lipid A, the endotoxic portion of lipopolysaccharide (LPS), as a strategy to evade host innate immune detection and establish persistent infection. Expression of modified lipid A species promotes pathogen evasion of host recognition by Toll-like receptor-4 (TLR4) and the non-canonical inflammasome. The Gram-negative oral anaerobe, <italic>Porphyromonas gingivalis</italic>, expresses lipid A structures that function as TLR4 agonists or antagonists, or are immunologically inert. It is currently unclear how modulation of <italic>P. gingivalis</italic> lipid A expression contributes to innate immune recognition, survival, and the ability of the pathogen to induce local and systemic inflammation. In this study, we demonstrate that <italic>P. gingivalis</italic> expression of antagonist lipid A species results in attenuated production of proinflammatory mediators and evasion of non-canonical inflammasome activation, facilitating bacterial survival in the macrophage. Infection of atherosclerosis-prone ApoE<sup>−/−</sup> mice with this strain resulted in progression of chronic inflammation in the vasculature. Notably, the ability of <italic>P. gingivalis</italic> to induce local inflammatory bone loss was independent of lipid A modifications, supporting distinct mechanisms for induction of local versus systemic inflammation. Our work demonstrates that evasion of immune detection at TLR4 contributes to pathogen persistence and facilitates low-grade chronic inflammation.</p>
</abstract>
<funding-group><funding-statement>This work was supported with grants from the NIH NIAID T32AI089673-01A1, NIAID PO1 AI078894-01A1, and NIAID 3RO1DE012768-12S1. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="14"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Host recognition of Gram-negative bacteria occurs via detection of LPS expressed on the bacterial membrane by the innate immune receptor, TLR4 <xref ref-type="bibr" rid="ppat.1004215-Akira1">[1]</xref>. This initial recognition is critical for instructing host immunity and promoting an inflammatory response that eradicates the pathogen from the host <xref ref-type="bibr" rid="ppat.1004215-Akira1">[1]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Munford1">[2]</xref>. However, a number of Gram-negative organisms have evolved mechanisms to modify their lipid A species, the component of bacterial LPS that directly activates the TLR4 complex, as a strategy to evade immune detection and establish infection <xref ref-type="bibr" rid="ppat.1004215-Miller1">[3]</xref>. Lipid A is initially synthesized as a β-1′,6-linked disaccharide of glucosamine that is phosphorylated and fatty acylated <xref ref-type="bibr" rid="ppat.1004215-Needham1">[4]</xref>. An unmodified version of this lipid A structure is typically expressed by <italic>E. coli</italic> and induces a robust inflammatory response <xref ref-type="bibr" rid="ppat.1004215-Raetz1">[5]</xref>. Modifications to this basic lipid A structure are observed in alterations to acyl chains or terminal phosphate groups <xref ref-type="bibr" rid="ppat.1004215-Coats1">[6]</xref>. <italic>Helicobacter pylori</italic> <xref ref-type="bibr" rid="ppat.1004215-Cullen1">[7]</xref>, <italic>Legionella pneumophila</italic> <xref ref-type="bibr" rid="ppat.1004215-Neumeister1">[8]</xref>, <italic>Yersinia pestis</italic> <xref ref-type="bibr" rid="ppat.1004215-Kawahara1">[9]</xref>, and <italic>Francisella novicida</italic> <xref ref-type="bibr" rid="ppat.1004215-Hajjar1">[10]</xref> express underacylated lipid A moieties, in comparison to the canonical LPS expressed by <italic>E. coli</italic>, and are poorly recognized by TLR4. <italic>Yersinia pestis</italic> <xref ref-type="bibr" rid="ppat.1004215-Rebeil1">[11]</xref> and <italic>Francisella tularensis</italic> <xref ref-type="bibr" rid="ppat.1004215-Li1">[12]</xref> expression of structurally divergent forms of lipid A is highly regulated by local environmental conditions such as temperature, allowing these pathogens to adapt to harsh environmental conditions in the host. It has been postulated that the ability of these pathogens to cause persistent infection and severe disease is partially due to evasion of host immune detection at TLR4 <xref ref-type="bibr" rid="ppat.1004215-Maeshima1">[13]</xref>.</p>
<p>Recently, it has been revealed that in addition to evasion of TLR4 signaling, lipid A modifications promote evasion of the non-canonical inflammasome by preventing activation of caspase-11 <xref ref-type="bibr" rid="ppat.1004215-Kayagaki1">[14]</xref>. Activation of the inflammasome is characterized by the production of the proinflammatory mediators IL-1β and IL-18 and is associated with downstream events such as pyroptosis <xref ref-type="bibr" rid="ppat.1004215-Franchi1">[15]</xref>. Due to its role in host innate defense, a number of pathogens have evolved strategies to evade activation of this complex <xref ref-type="bibr" rid="ppat.1004215-Taxman1">[16]</xref>. Pathogen evasion of inflammasome activation has been proposed to serve a dual role: to dampen cytokine production and to prevent host cell death in order to provide an intracellular niche for the pathogen to survive <xref ref-type="bibr" rid="ppat.1004215-Shimada1">[17]</xref>. One pathogen that has successfully adapted to evade the inflammasome is <italic>H. pylori</italic>, through expression of its tetra-acylated lipid A <xref ref-type="bibr" rid="ppat.1004215-Kayagaki1">[14]</xref>.</p>
<p>The oral pathogen <italic>Porphyromonas gingivalis</italic> weakly activates TLR4 through expression of a heterogeneous LPS that contains lipid A structures that vary in the number of phosphate groups and the amount and position of lipid A fatty acids <xref ref-type="bibr" rid="ppat.1004215-Bainbridge1">[18]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Kumada1">[19]</xref>. <italic>P. gingivalis</italic> expresses underacylated lipid A structures that can be penta-acylated forms, conferring TLR4 agonistic activity, or tetra-acylated forms, functioning as TLR4 antagonists, or are non-activating <xref ref-type="bibr" rid="ppat.1004215-Coats2">[20]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Reife1">[21]</xref>. These structures typically express mono- or di-phosphate terminal groups. Expression of divergent structural moieties by <italic>P. gingivalis</italic> changes depending on growth phase, temperature, and levels of hemin <xref ref-type="bibr" rid="ppat.1004215-AlQutub1">[22]</xref>–<xref ref-type="bibr" rid="ppat.1004215-Curtis1">[24]</xref>. Recently, it has been demonstrated that <italic>P. gingivalis</italic> also expresses a unique non-phosphorylated, tetra-acylated lipid A that is regulated by levels of hemin <xref ref-type="bibr" rid="ppat.1004215-Coats3">[23]</xref>. During hemin-deplete conditions, <italic>P. gingivalis</italic> utilizes endogenous lipid A 1- and 4′-phosphatase activities to express a non-phosphorylated, tetra-acylated lipid A that is immunologically inert at the TLR4 complex, as well as a mono-phosphorylated, penta-acylated lipid A that functions as a weak TLR4 agonist <xref ref-type="bibr" rid="ppat.1004215-AlQutub1">[22]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Coats3">[23]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Rangarajan1">[25]</xref>. Under hemin-replete conditions, the activity of 1-phosphatase is suppressed, resulting in the expression of a mono-phosphorylated, tetra-acylated lipid A species that functions as TLR4 antagonists <xref ref-type="bibr" rid="ppat.1004215-Coats3">[23]</xref>. Expression of these different structural types is believed to allow <italic>P. gingivalis</italic> to evade immune detection at TLR4 <xref ref-type="bibr" rid="ppat.1004215-Herath1">[26]</xref>.</p>
<p>A hallmark of chronic infection with <italic>P. gingivalis</italic> is the induction of a local inflammatory response that results in destruction of supporting tissues of the teeth and resorption of alveolar bone <xref ref-type="bibr" rid="ppat.1004215-Hayashi1">[27]</xref>–<xref ref-type="bibr" rid="ppat.1004215-Pihlstrom1">[29]</xref>. In addition to inflammation induced at the initial site of infection, <italic>P. gingivalis</italic> has been associated with systemic diseases such as diabetes, pre-term birth, pancreatic cancer, and cardiovascular disease <xref ref-type="bibr" rid="ppat.1004215-Bohnstedt1">[30]</xref>–<xref ref-type="bibr" rid="ppat.1004215-Michaud1">[32]</xref>. <italic>P. gingivalis</italic> has been detected in human atherosclerotic lesions and shown to be viable in atherosclerotic tissue <xref ref-type="bibr" rid="ppat.1004215-Haraszthy1">[33]</xref>–<xref ref-type="bibr" rid="ppat.1004215-Rosenfeld1">[35]</xref>. Studies from our laboratory have validated human studies by demonstrating that oral infection of atherosclerosis-prone ApoE<sup>−/−</sup> mice with <italic>P. gingivalis</italic> results in local oral bone loss and systemic inflammation in atherosclerotic lesions <xref ref-type="bibr" rid="ppat.1004215-Gibson1">[36]</xref>. We have demonstrated that <italic>P. gingivalis-</italic>induced oral inflammatory bone loss and acceleration of systemic inflammation and atherosclerosis is dependent on TLR2 signaling <xref ref-type="bibr" rid="ppat.1004215-Hayashi2">[37]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Papadopoulos1">[38]</xref>. <italic>P. gingivalis</italic> engages TLR2 through the expression of several outer membrane components that include lipoprotein, major and minor fimbriae, and phosphorylated dihydroceramides <xref ref-type="bibr" rid="ppat.1004215-Jain1">[39]</xref>–<xref ref-type="bibr" rid="ppat.1004215-Nichols1">[41]</xref>. The unique ability of <italic>P. gingivalis</italic> to induce TLR2 signaling and to evade TLR4 signaling has been proposed to enable this organism to cause low-grade persistent infection <xref ref-type="bibr" rid="ppat.1004215-Hayashi3">[42]</xref>; however, the expression of multiple <italic>P. gingivalis</italic> lipid A structures simultaneously has complicated the interpretation of how distinct lipid A moieties contribute to chronic inflammation <xref ref-type="bibr" rid="ppat.1004215-AlQutub1">[22]</xref>.</p>
<p>To define the role of distinct lipid A species in <italic>P. gingivalis</italic> evasion of TLR4 signaling, innate immune recognition, survival, and the ability of the pathogen to induce local and systemic chronic inflammation, we constructed genetically modified strains of <italic>P. gingivalis</italic> that lack either 1- or 4′-phosphatase activity <xref ref-type="bibr" rid="ppat.1004215-Coats3">[23]</xref>. These resulting strains express lipid A species that are not under genetic regulation and function as TLR4 agonists or TLR4 antagonists. Utilizing these strains, we demonstrate that <italic>P. gingivalis</italic> expression of antagonist lipid A species results in attenuated production of proinflammatory mediators and evasion of non-canonical inflammasome activation, facilitating bacterial survival in the macrophage. Infection of atherosclerosis-prone ApoE<sup>−/−</sup> mice with this strain resulted in progression of chronic inflammation in the vasculature. Notably, the ability of <italic>P. gingivalis</italic> to induce local inflammatory bone loss was independent of lipid A modifications, supporting distinct mechanisms for induction of local versus systemic inflammation. Collectively, these results indicate that expression of <italic>P. gingivalis</italic> lipid A structures that fail to engage TLR4 or function as TLR4 antagonists enables this pathogen to evade host innate immune detection and induce inflammation at sites distant from infection.</p>
</sec><sec id="s2">
<title>Results</title>
<sec id="s2a">
<title><italic>P. gingivalis</italic> strain 381 modifies its lipid A structures through expression of endogenous lipid A 1- and 4′-phosphatase activities</title>
<p>MALDI analysis of LPS isolated from <italic>P. gingivalis</italic> strain 381 revealed an ion cluster at m/z 1368 (<xref ref-type="fig" rid="ppat-1004215-g001"><bold>Figure 1A and 1D</bold></xref>). This structure represents the non-phosphorylated and tetra-acylated lipid A species that was predicted to be functionally inert at the TLR4 complex <xref ref-type="bibr" rid="ppat.1004215-Coats3">[23]</xref>. Additionally, we observed the expression of TLR4 antagonist (m/z 1448) and TLR4 agonist (m/z 1688 and m/z 1768) structures (<xref ref-type="fig" rid="ppat-1004215-g001"><bold>Figure 1A and 1E–G</bold></xref>). In order to examine the role of distinct lipid A species on the induction of inflammation, we constructed <italic>P. gingivalis</italic> strains lacking lipid A 1- and 4′- phosphatase activities in <italic>P. gingivalis</italic> 381. MALDI analysis of <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub>, that lacks 4′-phosphatase activity, revealed TLR4 agonist lipid A structures that centered at m/z 1768 and m/z 1688 (<xref ref-type="fig" rid="ppat-1004215-g001"><bold>Figure 1B and 1F–G</bold></xref>). MALDI analysis of <italic>P. gingivalis</italic> strain <italic>PG1773</italic><sub>381</sub>, which lacks 1-phosphatase activity, revealed a TLR4 antagonist lipid A mass ion that was predominantly centered at ∼1448 m/z as well as the agonistic lipid A centered at ∼1768 m/z (<xref ref-type="fig" rid="ppat-1004215-g001"><bold>Figure 1C, 1E and 1G</bold></xref>).</p>
<fig id="ppat-1004215-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004215.g001</object-id><label>Figure 1</label><caption>
<title><italic>P. gingivalis</italic> strain 381 utilizes endogenous lipid A 1- and 4′- phosphatase activities to modify lipid A species and evade TLR4 activation.</title>
<p>Lipid A isolated from <italic>P. gingivalis</italic> wild-type strain 381 (<bold>A</bold>) or lipid A mutant strains <italic>PG1587</italic><sub>381</sub> (<bold>B</bold>) and <italic>PG1773</italic><sub>381</sub> (<bold>C</bold>) were examined by MALDI-TOF MS. Arrows indicate the predominant lipid A species that are expressed for each strain (<bold>A–C</bold>). The major lipid A structures examined in this study have been identified in <italic>P. gingivalis</italic> as previously described (<bold>D–G</bold>) <xref ref-type="bibr" rid="ppat.1004215-Kumada1">[19]</xref>.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004215.g001" position="float" xlink:type="simple"/></fig>
<p>To confirm the predicted TLR4 activation phenotype of the lipid A expressed by wild-type 381 and the lipid A mutants, we stimulated HEK cells that overexpress mouse TLR4-MD2 with purified LPS from each strain. Notably, the LPS preparations purified from all three strains similarly activated mouse TLR4-MD2 (<xref ref-type="fig" rid="ppat-1004215-g002"><bold>Figure 2A</bold></xref>). In contrast, when live bacteria were used to stimulate the HEK cells only strain <italic>PG1587</italic><sub>381</sub> resulted in a significant increase in TLR4-dependent NF-κB activation as compared to wild-type 381 and <italic>PG1773</italic><sub>381</sub> (<xref ref-type="fig" rid="ppat-1004215-g002"><bold>Figure 2B</bold></xref>). These results suggest that the lipid A structures are differentially distributed within the bacterial cell membranes depending upon the strains, and that the relative localization of the specific agonistic and antagonistic lipid A forms to the outer cell membrane determines the respective abilities of the different strains to activate TLR4. The less potent lipid A forms (m/z 1368, 1448, 1688) may be primarily expressed on the bacterial outer membrane whereas the most potent lipid A form (m/z 1768) predominates in the inner membrane where it is initially synthesized prior to processing by phosphatases and deacylase(s).</p>
<fig id="ppat-1004215-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004215.g002</object-id><label>Figure 2</label><caption>
<title>Lipid A phosphatase activity contributes to the ability of <italic>P. gingivalis</italic> to evade host innate immune defenses.</title>
<p>HEK cells overexpressing mouse TLR4-MD2 (<bold>A–B</bold>) or TLR2 (<bold>D–E</bold>) were stimulated with corresponding LPS concentration purified from each strain (<bold>A,D</bold>) or whole bacterium (<bold>B,E</bold>) overnight. Relative NFkB activity indicates inducible firefly luciferase activity over the media control. Wild-type 381 and the lipid A mutants <italic>PG1587</italic><sub>381</sub> and <italic>PG1773</italic><sub>381</sub> were grown in BHI broth cultures overnight in the presence or absence of polymyxin B (PMB 1, 5, 10, 25, 50 µg/mL). Growth was measured by spectrophotometry (OD<sub>660</sub>) (<bold>C</bold>). Wild-type <italic>P. gingivalis</italic> (<bold>solid</bold>), <italic>PG1587</italic><sub>381</sub> (<bold>dotted</bold>), and <italic>PG1773</italic><sub>381</sub> (<bold>dashed</bold>). Graphs show the mean ± SEM of triplicate wells and are representative of two independent experiments. (See also <bold><xref ref-type="supplementary-material" rid="ppat.1004215.s001">Figure S1</xref></bold>).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004215.g002" position="float" xlink:type="simple"/></fig>
<p>In addition to direct impact on TLR4 activation, modifications in lipid A structure can significantly alter the ability of cationic peptides to kill bacteria. We have previously reported that two different strains of <italic>P. gingivalis</italic> (33277 and A7436) deficient in <italic>PG1587</italic> exhibit the most pronounced sensitivity to polymyxin B as compared to the wild-type and <italic>PG1773</italic> strains, consistent with a critical role of the lipid A 4′-phosphate in rendering bacteria susceptible to this drug <xref ref-type="bibr" rid="ppat.1004215-Coats3">[23]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Zenobia1">[43]</xref>. Assessment of these mutations in the 381 strains revealed a comparable pattern. Strain <italic>PG1587</italic><sub>381</sub> exhibits a pronounced susceptibility to polymyxin B while the <italic>P. gingivalis</italic> wild-type strain 381 and strain <italic>PG1773</italic><sub>381</sub> were relatively more resistant (<xref ref-type="fig" rid="ppat-1004215-g002"><bold>Figure 2C</bold></xref>). These data correlate well with the above TLR4 activation data indicating that lipid A structures localized in the outer membrane of the <italic>PG1587</italic><sub>381</sub> mutant contain 4′-phosphate (m/z 1688). In contrast, the <italic>PG1773</italic><sub>381</sub> strain is the most resistant, indicating the predominance of lipid A lacking 4′-phosphate in the outer membrane (m/z 1448). Wild-type 381 has an intermediate polymyxin B resistance phenotype consistent with an increased presence of lipid A containing 4′-phosphate as compared to strain <italic>PG1773</italic><sub>381</sub>.</p>
<p>To verify that the mutant 381 strains exhibit phenotypes that are consistent with bacterial surface lipid A modifications rather than modifications of other surface virulence factors, we further assessed the ability of the <italic>P. gingivalis</italic> wild-type strain and the lipid A mutants to activate TLR2. All three <italic>P. gingivalis</italic> strains induced a similarly significant increase in NF-κB activation in HEK293 cells over expressing TLR2; however, we observed a slight decrease in the ability of the <italic>P. gingivalis</italic> wild-type strain 381 to activate TLR2 at lower MOIs (<xref ref-type="fig" rid="ppat-1004215-g002"><bold>Figure 2E</bold></xref><bold> and data not shown</bold>). Stimulation of HEK-TLR2 cells with purified LPS isolated from the <italic>P. gingivalis</italic> wild-type strain 381 and the lipid A mutants resulted in equivalent activation of TLR2 (<xref ref-type="fig" rid="ppat-1004215-g002"><bold>Figure 2D</bold></xref>). These results were expected since <italic>P. gingivalis</italic> strongly activates TLR2 via expression of fimbriae and lipoproteins <xref ref-type="bibr" rid="ppat.1004215-Jain1">[39]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Davey1">[40]</xref>. To confirm that modification of lipid A structures in <italic>P. gingivalis</italic> strains <italic>PG1587</italic><sub>381</sub> and <italic>PG1773</italic><sub>381</sub> did not alter the expression of other outer membrane components, we examined the major fimbriae protein and activity of the cell-associated cysteine proteases, gingipain R and gingipain K. Similar levels of fimbriae expression were observed in <italic>P. gingivalis</italic> strains 381, <italic>PG1587</italic><sub>381</sub> and <italic>PG1773</italic><sub>381</sub> (<bold><xref ref-type="supplementary-material" rid="ppat.1004215.s001">Figure S1</xref>-A-B</bold>). We observed a slight decrease in gingipain activity (KGP and RGP) in <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub> as compared to that observed in the wild-type strain (<bold><xref ref-type="supplementary-material" rid="ppat.1004215.s001">Figure S1</xref>-C</bold>). We did not observe significant differences in the growth of <italic>P. gingivalis</italic> strains <italic>PG1587</italic><sub>381</sub> and <italic>PG1773</italic><sub>381</sub> as compared to the wild-type strain (<bold><xref ref-type="supplementary-material" rid="ppat.1004215.s001">Figure S1</xref>-D and data not shown</bold>). Taken together, these results indicate that deletion of <italic>PG1587</italic> or <italic>PG1773</italic> alters the ability of the whole bacteria to activate TLR4 but does not alter the expression of other outer membrane components or the ability of the pathogen to activate TLR2. Therefore, the use of strains <italic>PG1587</italic><sub>381</sub> and <italic>PG1773</italic><sub>381</sub> in this study allowed us to assess the immunological consequences of differential lipid A expression by <italic>P. gingivalis</italic>.</p>
</sec><sec id="s2b">
<title><italic>P. gingivalis</italic> expression of antagonistic lipid A attenuates induction of TLR4-dependent inflammatory mediators</title>
<p>We examined the ability of the <italic>P. gingivalis</italic> strains lacking lipid A 1- and 4′-phosphatase activities to induce NF-κB-dependent proinflammatory cytokines in bone marrow-derived macrophages (BMDM). Stimulation of BMDM with <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub> resulted in increased production of KC, IL-6, IL-1β, and IL-1α compared to <italic>P. gingivalis</italic> strains 381 and <italic>PG1773</italic><sub>381</sub> in a dose-dependent manner (<xref ref-type="fig" rid="ppat-1004215-g003"><bold>Figure 3B–C</bold></xref><bold>; </bold><xref ref-type="fig" rid="ppat-1004215-g004"><bold>Figure 4A–B</bold></xref>). In contrast, all three <italic>P. gingivalis</italic> strains induced significant levels of TNF-α. (<xref ref-type="fig" rid="ppat-1004215-g003"><bold>Figure 3A</bold></xref>). The role of TLR2 and TLR4 in the production of these inflammatory cytokines was assessed in BMDM obtained from TLR2- and TLR4-deficient mice. <italic>P. gingivalis</italic>-induced TNF-α production required both TLR2 and TLR4 signaling; however, TLR2 signaling was more dominant (<xref ref-type="fig" rid="ppat-1004215-g003"><bold>Figure 3D</bold></xref>). Additionally, we observed that the ability of <italic>P. gingivalis</italic> to induce IL-1β and IL-1α was dependent on both TLR2 and TLR4 signaling (<bold><xref ref-type="supplementary-material" rid="ppat.1004215.s002">Figure S2</xref></bold>). In contrast, <italic>P. gingivalis</italic>-induced expression of KC and IL-6 were primarily dependent on TLR4 signaling (<xref ref-type="fig" rid="ppat-1004215-g003"><bold>Figure 3E–F</bold></xref>). We observed that <italic>PG1587</italic><sub>381</sub> induced enhanced KC and IL-6 levels in TLR2-deficient macrophages as compared to the <italic>P. gingivalis</italic> wild-type strain 381, suggesting the increased cytokine production we observed in wild-type BMDM was mediated via TLR4 signaling. Furthermore, we observed comparable KC and IL-6 levels in BMDM deficient in TLR4 following stimulation with all 3 strains of <italic>P. gingivalis</italic>, suggesting additional signaling through TLR2 in the absence of TLR4 or an inability of lipid A to antagonize production of these cytokines. Overall, these results indicate that expression of antagonistic or inert lipid A attenuates the production of NFκB-dependent proinflammatory mediators in macrophages.</p>
<fig id="ppat-1004215-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004215.g003</object-id><label>Figure 3</label><caption>
<title>Expression of antagonistic or inert lipid A attenuates the production of NFkB-dependent proinflammatory mediators.</title>
<p>BMDMs from C57BL/6 were stimulated with <italic>P. gingivalis</italic> wild-type strain 381 (381) or the lipid A mutant strains <italic>PG1587</italic><sub>381</sub> (1587) and <italic>PG1773</italic><sub>381</sub> (1773) at an MOI of 1 (<bold>white</bold>) 10 (<bold>gray</bold>) and 100 (<bold>black</bold>). Levels of TNFα (<bold>A</bold>), KC (<bold>B</bold>), and IL-6 (<bold>C</bold>) were assayed by ELISA at 24 h. BMDMs from wild-type C57BL/6 mice (<bold>white</bold>), TLR2-deficient (<bold>gray</bold>), or TLR4-deficient (<bold>black</bold>) were stimulated with <italic>P. gingivalis</italic> wild-type strain 381 or the lipid A mutant strains at an MOI of 100 (<bold>D</bold>) or MOI of 10 (<bold>E–F</bold>) and levels of TNFα (<bold>D</bold>) KC (<bold>E</bold>) and IL-6 (<bold>F</bold>) were assessed by ELISA at 24 h (See also <bold><xref ref-type="supplementary-material" rid="ppat.1004215.s002">Figure S2</xref></bold>). Cells treated with <italic>E. coli</italic> LPS (100 ng/mL) or Pam3CysSk4 (1 µg/mL) for 5 h served as a positive control. Graphs show the mean ± SEM of triplicate wells and are representative of three independent experiments. *p&lt;.05 **p≤.001 ***p&lt;.0001; ANOVA with Bonferroni's posttest.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004215.g003" position="float" xlink:type="simple"/></fig><fig id="ppat-1004215-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004215.g004</object-id><label>Figure 4</label><caption>
<title><italic>P. gingivalis</italic> evades activation of the inflammasome through expression of modified lipid A species.</title>
<p>C57BL/6 WT BMDM were stimulated with <italic>P. gingivalis</italic> wild-type strain 381 or the lipid A mutant strains <italic>PG1587</italic><sub>381</sub> and <italic>PG1773</italic><sub>381</sub> at an MOI of 1 (<bold>white</bold>), 10 (<bold>gray</bold>) or 100 (<bold>black</bold>). Levels of IL-1β (<bold>A</bold>) and IL-1α (<bold>B</bold>) were assayed by ELISA at 24 h. LDH release (Promega) was assayed in BMDM stimulated with <italic>P. gingivalis</italic> wild-type strain 381 or the lipid A mutants at an MOI 100 at 2 h (<bold>white</bold>), 6 h (<bold>gray</bold>) and 24 h (<bold>black</bold>) (<bold>C</bold>). BMDM from wild-type (<bold>white bars</bold>) and caspase-11-deficient (<bold>black bars</bold>) mice were stimulated with <italic>P. gingivalis</italic> wild-type strain 381 or the lipid A mutants at an MOI of 100 and levels of IL-1β (<bold>D</bold>) and IL-1α (<bold>E</bold>) were assessed by ELISA at 24 h. Viable counts (CFU) of internalized <italic>P. gingivalis</italic> were determined by plating serial dilutions of macrophage lysates on blood agar plates at 2 h (<bold>white</bold>) and 6 h (<bold>gray</bold>) (<bold>F</bold>). Western blot analysis was performed on BMDM cell lysates to assess levels of the proform of IL-1β, pro Caspase-1 and β-actin at 24 h (<bold>G</bold>). Levels of mature IL-1β and active caspase-1 (p10) were detected in cell supernatants. BMDMs treated with media alone (−) or with <italic>E. coli</italic> LPS (100 ng/mL) for 5 h and then ATP (5 mM) for 20 m (+) served as the negative and positive control respectively. Graphs depict the mean ± SEM of triplicate wells and are representative of at least three independent experiments. * p&lt;.05 **p≤.001 ***p&lt;.0001; two-tailed unpaired t-tests. (See also <bold><xref ref-type="supplementary-material" rid="ppat.1004215.s002">Figure S2</xref></bold>).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004215.g004" position="float" xlink:type="simple"/></fig></sec><sec id="s2c">
<title><italic>P. gingivalis</italic> evades inflammasome activation through expression of lipid A structures that evade TLR4 detection</title>
<p>IL-1β is considered an “alarm” cytokine and has been shown to be critical for host defense against infection <xref ref-type="bibr" rid="ppat.1004215-Taxman1">[16]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Tschopp1">[44]</xref>. Previous studies have documented that <italic>P. gingivalis</italic> fails to induce significant levels of IL-1β production in macrophages <xref ref-type="bibr" rid="ppat.1004215-Bostanci1">[45]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Taxman2">[46]</xref>. Thus, the increased production of IL-1β observed in macrophages stimulated with <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub> was an unexpected finding (<xref ref-type="fig" rid="ppat-1004215-g004"><bold>Figure 4A</bold></xref>). IL-1β is first produced as an inactive zymogen, through activation of TLR signaling <xref ref-type="bibr" rid="ppat.1004215-Mariathasan1">[47]</xref>. We observed that all three <italic>P. gingivalis</italic> strains induced expression of the proform of IL-1β (<xref ref-type="fig" rid="ppat-1004215-g004"><bold>Figure 4G</bold></xref>), which was dependent on TLR2 and TLR4 (<bold>data not shown</bold>). These results indicated that the attenuated production of IL-1β observed with <italic>P. gingivalis</italic> strains 381 and <italic>PG1773</italic><sub>381</sub> was not due to an obstruction of TLR-mediated synthesis of pro-IL-1β.</p>
<p>These findings led us to investigate the role of <italic>P. gingivalis</italic> lipid A modifications on inflammasome activation, the second signal required for production of mature and active IL-1β. Stimulation of macrophages with <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub> resulted in activation of the inflammasome, as assessed by detection of the active caspase-1 p10 subunit in cell supernatants by Western blot analysis (<xref ref-type="fig" rid="ppat-1004215-g004"><bold>Figure 4G</bold></xref>). We also observed an increase in macrophage cell lysis following stimulation with <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub> (<xref ref-type="fig" rid="ppat-1004215-g004"><bold>Figure 4C</bold></xref>), an event that is downstream from inflammasome activation. These results correlated with an inability of <italic>PG1587</italic><sub>381</sub> to survive in macrophages. We observed a significant decrease in survival of <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub> in macrophages compared to <italic>P. gingivalis</italic> strains 381 and strain <italic>PG1773</italic><sub>381</sub> (<xref ref-type="fig" rid="ppat-1004215-g004"><bold>Figure 4F</bold></xref>).</p>
<p>Caspase-11 has emerged as an important mediator of inflammasome activation in Gram-negative bacterial infections <xref ref-type="bibr" rid="ppat.1004215-Kayagaki2">[48]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Rathinam1">[49]</xref>. We thus examined the role of caspase-11 in <italic>P. gingivalis</italic>-induced IL-1β production. Interestingly, IL-1β production was completely ablated in macrophages deficient in caspase-11 following stimulation with <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub> (<xref ref-type="fig" rid="ppat-1004215-g004"><bold>Figure 4D</bold></xref>), while TNFα levels were not altered (data not shown). In agreement with the requirement for caspase-11 in IL-1α production <xref ref-type="bibr" rid="ppat.1004215-Broz1">[50]</xref>, we observed decreased production of IL-1α following stimulation of BMDM obtained from caspase-11-deficient mice with <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub>. However, we did not observe significant differences in the levels of IL-1α in BMDM obtained from caspase-11-deficient mice when stimulated with wild-type 381 compared to strain <italic>PG1587</italic><sub>381</sub> (<xref ref-type="fig" rid="ppat-1004215-g004"><bold>Figure 4E</bold></xref>). These results suggest distinct mechanism(s) for IL-1α production independent of lipid A modifications. Collectively, these findings indicate that expression of modified lipid A species by <italic>P. gingivalis</italic> facilitates evasion of non-canonical inflammasome activation through a caspase-11-mediated pathway and obstructs downstream events associated with activation of this complex.</p>
</sec><sec id="s2d">
<title>Alternative lipid A structures produced by <italic>P. gingivalis</italic> differentially influence systemic inflammation and local oral inflammation</title>
<p>To determine if the expression of modified lipid A by <italic>P. gingivalis</italic> is associated with the ability of the organism to promote chronic inflammation <italic>in vivo</italic>, we utilized a mouse model that mimics chronic <italic>P. gingivalis</italic> exposure as seen during human infection <xref ref-type="bibr" rid="ppat.1004215-Baker1">[51]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Chou1">[52]</xref>. Atherosclerosis-prone ApoE<sup>−/−</sup> mice were orally infected with <italic>P. gingivalis</italic> strains 381, <italic>PG1587</italic><sub>381</sub>, and <italic>PG1773</italic><sub>381</sub> and chronic inflammation at local (oral bone loss) and systemic (atherosclerosis) sites was evaluated <xref ref-type="bibr" rid="ppat.1004215-Gibson1">[36]</xref>.</p>
<p>Plaque accumulation in the innominate artery was examined by magnetic resonance angiogram (MRA) throughout the course of the study to assess progression of site-specific inflammatory atherosclerosis. The innominate artery exhibits a high degree of lesion progression and expresses features of human disease including vessel narrowing and perivascular inflammation <xref ref-type="bibr" rid="ppat.1004215-Hayashi4">[53]</xref>. MRA at 8 weeks after oral infection resulted in an increase in the change of luminal area for mice infected with all 3 strains, indicating that the mice were still growing at this age (14–16 weeks of age) (<xref ref-type="fig" rid="ppat-1004215-g005"><bold>Figure 5A</bold></xref>). At 16 weeks after oral infection, MRA revealed that oral infection with <italic>P. gingivalis</italic> strains 381 and strain <italic>PG1773</italic><sub>381</sub> resulted in significant luminal narrowing compared to sham-infected controls (<xref ref-type="fig" rid="ppat-1004215-g005"><bold>Figure 5A</bold></xref>). In contrast, oral infection with <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub> induced minimal luminal narrowing compared to sham-infected controls (<xref ref-type="fig" rid="ppat-1004215-g005"><bold>Figure 5A</bold></xref>). Furthermore, <italic>P. gingivalis</italic> strains 381 and <italic>PG1773</italic><sub>381</sub> induced progressive luminal narrowing from 8 to 16wks compared to strain <italic>PG1587</italic><sub>381</sub> and sham-infected controls (<xref ref-type="fig" rid="ppat-1004215-g005"><bold>Figure 5A</bold></xref><bold> </bold><bold><italic>inset</italic></bold>).</p>
<fig id="ppat-1004215-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004215.g005</object-id><label>Figure 5</label><caption>
<title>Expression of immunologically silent or antagonistic lipid A structures exacerbates atherosclerotic plaque progression in the innominate artery.</title>
<p>Innominate arteries of ApoE<sup>−/−</sup> mice were imaged by MRA at baseline (wk 0) and at 8 and 16 wks after first oral infection. The temporal change in luminal area (mm<sup>2</sup>) was calculated for individual mice normalized to baseline luminal area (n = 10–12/group) (<bold>A</bold>). Sham-infected ApoE<sup>−/−</sup> (<bold>orange</bold>); 381-infected ApoE<sup>−/−</sup> (<bold>black</bold>); <italic>PG1587</italic><sub>381</sub>-infected ApoE<sup>−/−</sup> (<bold>blue</bold>); <italic>PG1773</italic><sub>381</sub>- infected ApoE<sup>−/−</sup> (<bold>red</bold>). <italic>Inset</italic> - the temporal change in luminal area calculated for individual mice normalized to 8 wk luminal area (n = 10–12/group). *p≤.01 **p&lt;.001 ***p&lt;.0001; two-tailed unpaired t-tests compared to sham-infected and <italic>PG1587</italic><sub>381</sub>-infected mice. (<bold>B</bold>) Representative images of the innominate artery with F4/80 staining (macrophages stain brown) and hematoxylin counterstaining for each group at 10× and 40× (n = 3/group) (See also <bold><xref ref-type="supplementary-material" rid="ppat.1004215.s003">Figure S3</xref></bold>).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004215.g005" position="float" xlink:type="simple"/></fig>
<p>Luminal narrowing was further validated by histological assessment of the innominate artery in postmortem sections. Hematoxylin and eosin staining of the innominate artery corresponding to the region of MRA analysis revealed an occlusion of the lumen in ApoE<sup>−/−</sup> mice infected with <italic>P. gingivalis</italic> strain 381 (<bold><xref ref-type="supplementary-material" rid="ppat.1004215.s003">Figure S3</xref></bold>), in agreement with our previous studies <xref ref-type="bibr" rid="ppat.1004215-Hayashi4">[53]</xref>. Oral infection with <italic>P. gingivalis</italic> strain <italic>PG1773</italic><sub>381</sub> resulted in plaque accumulation that was comparable to that observed with <italic>P. gingivalis</italic> strain 381 (<bold><xref ref-type="supplementary-material" rid="ppat.1004215.s003">Figure S3</xref></bold>). Oral infection with <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub> resulted in thickening of the vessel wall without occlusion of the vasculature (<bold><xref ref-type="supplementary-material" rid="ppat.1004215.s003">Figure S3</xref></bold>). To assess macrophage infiltrate of the atherosclerotic lesions, histological sections of the innominate artery were stained with F4/80. We found oral infection with <italic>P. gingivalis</italic> strains 381 and <italic>PG1773</italic><sub>381</sub> resulted in an increase in macrophage accumulation in the innominate lesions compared to that observed with <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub> and sham-infected controls (<xref ref-type="fig" rid="ppat-1004215-g005"><bold>Figure 5B</bold></xref>).</p>
<p>Lipid staining of <italic>en face</italic> aortas revealed that oral infection with <italic>P. gingivalis</italic> strains 381 and <italic>PG1773</italic><sub>381</sub> accelerated plaque accumulation compared to that observed in sham-infected mice (<xref ref-type="fig" rid="ppat-1004215-g006"><bold>Figure 6</bold></xref>). In contrast, oral infection with <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub> induced minimal plaque accumulation (<xref ref-type="fig" rid="ppat-1004215-g006"><bold>Figure 6C</bold></xref>). The inability of <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub> to elicit inflammatory disease pathology was not due to failed activation of immunity, since we observed an induction of the humoral response by <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub> that was comparable to that induced by <italic>P. gingivalis</italic> strains 381 and strain <italic>PG1773</italic><sub>381</sub>, as observed by serum levels of IgG1, IgG2b, IgG2c and IgG3 (<bold><xref ref-type="supplementary-material" rid="ppat.1004215.s004">Figure S4</xref></bold>).</p>
<fig id="ppat-1004215-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004215.g006</object-id><label>Figure 6</label><caption>
<title>Expression of immunologically silent or antagonistic lipid A structures exacerbates atherosclerotic plaque progression in the aorta.</title>
<p>Plaque area was determined from Oil Red O staining for lipids in <italic>en face</italic> aortic lesions 16 wk after first infection from (<bold>A</bold>) sham-infected, (<bold>B</bold>) wild-type 381, (<bold>C</bold>) <italic>PG1587</italic><sub>381</sub>, and (<bold>D</bold>) <italic>PG1773</italic><sub>381</sub>. (<bold>E</bold>) Quantification of lipid content within total aorta was calculated using ImageJ software (NIH) (n = 8/group). * p&lt;.05; two-tailed unpaired t-tests. (See also <bold><xref ref-type="supplementary-material" rid="ppat.1004215.s004">Figure S4</xref></bold>).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004215.g006" position="float" xlink:type="simple"/></fig>
<p>Assessment of alveolar bone loss in infected mice revealed that <italic>P. gingivalis</italic> strains 381, <italic>PG1587</italic><sub>381</sub>, and <italic>PG1773</italic><sub>381</sub> all induced oral bone loss at similar levels (<xref ref-type="fig" rid="ppat-1004215-g007"><bold>Figure 7</bold></xref>). These results are consistent with studies demonstrating a predominant role for TLR2 signaling in <italic>P. gingivalis</italic>-induced oral inflammatory bone loss <xref ref-type="bibr" rid="ppat.1004215-Burns1">[54]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Ukai1">[55]</xref>. Collectively, these results indicate that expression of <italic>P. gingivalis</italic> lipid A structures that fail to engage TLR4 or function as TLR4 antagonists enables this pathogen to evade host innate immune detection and contributes to inflammation at sites distant from infection.</p>
<fig id="ppat-1004215-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004215.g007</object-id><label>Figure 7</label><caption>
<title>Expression of immunologically silent, agonistic or antagonistic lipid A does not alter the ability of the pathogen to induce oral bone loss.</title>
<p>Maxillae were dissected (n = 8/group) 16 wk post initial infection and scanned on a micro CT 40 apparatus. Using AMIRA software, three-dimensional images were generated from micro CT scans. Representative images from (<bold>A</bold>) sham-infected mouse indicating no bone loss, (<bold>B</bold>) <italic>P. gingivalis</italic> wild-type strain 381-induced bone loss, (<bold>C</bold>) <italic>PG1587</italic><sub>381</sub>, and (<bold>D</bold>) <italic>PG1773</italic><sub>381</sub>. (<bold>E</bold>) Quantification of bone loss. ***p&lt;.001; two-tailed unpaired t-tests.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004215.g007" position="float" xlink:type="simple"/></fig></sec><sec id="s2e">
<title>Discussion</title>
<p>In this study, we generated genetically defined strains of <italic>P. gingivalis</italic> expressing TLR4 agonist and antagonist lipid A species to examine the role of TLR4 evasion in <italic>P. gingivalis</italic>-induced chronic inflammation. Importantly, we determined that expression of TLR4 antagonist lipid A contributes to the ability of <italic>P. gingivalis</italic> to activate innate immunity and induce inflammation at systemic sites. Notably, induction of local inflammatory bone loss in response to <italic>P. gingivalis</italic> infection was not dependent on lipid A modifications, indicative of distinct mechanisms for the induction of local versus systemic vascular chronic inflammation. The expression of antagonistic or immunological inert lipid A species was associated with attenuated production of proinflammatory mediators and inflammasome activation, which correlated with increased bacterial survival in macrophages. We conclude that <italic>P. gingivalis</italic> evades TLR4-mediated bacterial clearance in the host, allowing it to exacerbate vascular inflammation (<xref ref-type="fig" rid="ppat-1004215-g008"><bold>Figure 8</bold></xref>).</p>
<fig id="ppat-1004215-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1004215.g008</object-id><label>Figure 8</label><caption>
<title><italic>P. gingivalis</italic> dysregulates host cell immune activation facilitating systemic inflammation.</title>
<p>The host predominantly senses <italic>P. gingivalis</italic> infection through engagement of TLR2 while the involvement of TLR4-dependent recognition is significantly impaired. Expression of antagonistic or immunologically inert lipid A by <italic>P. gingivalis</italic> attenuates production of proinflammatory mediators and prevents activation of the inflammasome (potentially through evasion of an unknown sensor) that facilitates intracellular survival. These events allow the pathogen to disseminate and to exacerbate systemic inflammation. In contrast, increased immunostimulatory potential at TLR4, through expression of an agonistic lipid A moiety, results in increased production of proinflammatory mediators, inflammasome activation, and reduced survival of the bacterium in macrophages leading to attenuated systemic inflammation.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.ppat.1004215.g008" position="float" xlink:type="simple"/></fig>
<p>We and others have reported that the expression of <italic>P. gingivalis</italic> lipid A is regulated by growth phase, temperature, and levels of hemin <xref ref-type="bibr" rid="ppat.1004215-AlQutub1">[22]</xref>–<xref ref-type="bibr" rid="ppat.1004215-Curtis1">[24]</xref>. The expression of multiple lipid A structures has complicated the interpretation of the host response elicited by <italic>P. gingivalis</italic> LPS <xref ref-type="bibr" rid="ppat.1004215-AlQutub1">[22]</xref>. During growth under hemin-replete conditions, <italic>P. gingivalis</italic> expresses an antagonistic lipid A, due to the repression of 1-phosphatase activity <xref ref-type="bibr" rid="ppat.1004215-Coats3">[23]</xref>. The antagonist lipid A expressed by <italic>P. gingivalis</italic> has been demonstrated to antagonize <italic>E. coli</italic> LPS binding to TLR4 <xref ref-type="bibr" rid="ppat.1004215-Coats4">[56]</xref> and to dampen the cytokine response typically induced by other Gram-negative pathogens <xref ref-type="bibr" rid="ppat.1004215-Bostanci1">[45]</xref>. The use of <italic>P. gingivalis</italic> strain <italic>PG1773</italic><sub>381</sub> in this study allowed us to specifically define the role of the antagonistic lipid A (typically expressed under hemin-replete conditions) in the induction of chronic inflammation at both local and distant sites from infection. We observed that <italic>P. gingivalis</italic> strains 381 and <italic>PG1773</italic><sub>381</sub> induced comparable levels of inflammatory atherosclerosis suggesting that <italic>in vivo P. gingivalis</italic> is exposed to a hemin-replete environment and predominantly expresses an antagonistic lipid A that exacerbates chronic systemic inflammation.</p>
<p>Evasion of TLR4 signaling through lipid A modifications has been attributed to the ability of a number of highly pathogenic Gram-negative pathogens to cause disease <xref ref-type="bibr" rid="ppat.1004215-Miller1">[3]</xref>. For example, <italic>F. novicida</italic> expresses a tetra-acylated lipid A, with one phosphate group and does not induce a TLR4 response <xref ref-type="bibr" rid="ppat.1004215-Hajjar1">[10]</xref>. <italic>Y. pestis</italic> expresses a tetra-acylated lipid A that functions as a TLR4 antagonist at 37°C, which allows this pathogen to remain undetected in the bloodstream during early stages of infection <xref ref-type="bibr" rid="ppat.1004215-Kawahara1">[9]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Rebeil1">[11]</xref>. Generation of a strain of <italic>Y. pestis</italic> that expressed a more immunostimulatory LPS conferred a protective immune response against this pathogen <xref ref-type="bibr" rid="ppat.1004215-Montminy1">[57]</xref>. Likewise, <italic>Pseudomonas aeruginosa</italic> expresses a modified LPS which promotes evasion of TLR4 signaling, favors intracellular survival, and has been postulated to contribute to chronic persistence in Cystic Fibrosis patients <xref ref-type="bibr" rid="ppat.1004215-Cigana1">[58]</xref>. In agreement with these studies, we have shown that <italic>P. gingivalis</italic> modifies its lipid A structure in order to evade host defenses and establish chronic infection leading to persistent low-grade inflammation in the vasculature. Uniquely, <italic>P. gingivalis</italic> evasion of host innate immunity at TLR4 results in progression of inflammation at a site that is distant from local infection by gaining access to the vasculature.</p>
<p>A number of reports have proposed that <italic>P. gingivalis</italic> lipid A modifications are a mechanism for evasion of TLR4 signaling <xref ref-type="bibr" rid="ppat.1004215-Coats1">[6]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Coats3">[23]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Herath1">[26]</xref>. However, these studies utilized purified <italic>P. gingivalis</italic> LPS in an <italic>in vitro</italic> setting. To date, only this study and our recent study in a rabbit model of periodontitis <xref ref-type="bibr" rid="ppat.1004215-Zenobia1">[43]</xref> have begun to shed light on the immunological consequences of differential activation of the TLR4 complex by <italic>P. gingivalis</italic> LPS through the use of live bacteria that express a “locked” lipid A profile that is not responsive to growth conditions. Furthermore, we assessed the host response in the oral cavity and vasculature, physiologically relevant sites of chronic inflammation observed in humans. Notably, the use of purified LPS in our study resulted in discrepancies in TLR4 activation by isolated LPS versus the whole bacterium. These differences observed in the host response may be a reflection of LPS structure and composition on the cell surface, which leave us with new areas of investigation with regards to LPS translocation. Potentially, the less potent lipid A forms (m/z 1368, 1448, 1688) may be primarily expressed on the bacterial outer membrane and, consequently, render wild-type 381 and <italic>PG1773</italic><sub>381</sub> unable to activate TLR4. In contrast, strain <italic>PG1587</italic><sub>381</sub> is expected to exclusively accumulate lipid A TLR4 agonists (m/z 1688 and possibly m/z 1768) in the outer membrane since the presence of a lipid A 4′-phosphate precludes production of the lipid A antagonist (m/z 1448) or non-activating lipid A (m/z 1368) in this strain.</p>
<p>Overproduction of proinflammatory mediators and dysregulated inflammasome activation has been reported to contribute to inflammatory pathology in a number of chronic diseases <xref ref-type="bibr" rid="ppat.1004215-Davis1">[59]</xref>. Paradoxically, we observed that increased stimulation of TLR4 by <italic>P. gingivalis</italic> enhanced production of proinflammatory mediators and activation of the inflammasome, resulting in attenuated systemic inflammation (<xref ref-type="fig" rid="ppat-1004215-g008"><bold>Figure 8</bold></xref>). These results indicate that production of inflammatory mediators is protective against pathogen-mediated chronic inflammation, which is in agreement with our recent results that documented a protective role for TLR4 in <italic>P. gingivalis-</italic>mediated chronic inflammation at systemic sites <xref ref-type="bibr" rid="ppat.1004215-Hayashi3">[42]</xref>. This report, along with our current study, is in contrast to other studies elucidating the role of TLR4 in pathogen-mediated atherosclerosis progression. Infection of ApoE<sup>−/−</sup> TLR4<sup>−/−</sup> mice, fed a high-fat diet, with <italic>C. pneumoniae</italic> resulted in diminished atherosclerosis compared to ApoE<sup>−/−</sup> infected mice <xref ref-type="bibr" rid="ppat.1004215-Naiki1">[60]</xref>. Additionally, a previous study documented that common mechanisms of signaling via TLR2, TLR4 and MyD88 link stimulation by multiple pathogens and endogenous ligands to atherosclerosis progression <xref ref-type="bibr" rid="ppat.1004215-Michelsen1">[61]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Cole1">[62]</xref>. Therapeutic antagonism has been suggested to be beneficial in the treatment of chronic atherosclerosis <xref ref-type="bibr" rid="ppat.1004215-Leon1">[63]</xref>. However, we have demonstrated TLR4 antagonism exacerbates atherosclerosis progression. Collectively, our study highlights the complexity of chronic inflammatory pathways in diseases like atherosclerosis that are exacerbated by pathogen infection and further elucidate pathogen-specific mechanisms for chronic disease progression.</p>
<p>An important observation from this study was that <italic>P. gingivalis</italic> failed to activate the inflammasome. It has recently been reported that Gram-negative bacteria utilize a non-canonical pathway for inflammasome activation that is mediated by caspase-11 <xref ref-type="bibr" rid="ppat.1004215-Kayagaki2">[48]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Rathinam1">[49]</xref>. Kayagaki et al. <xref ref-type="bibr" rid="ppat.1004215-Kayagaki1">[14]</xref> have shown that <italic>H. pylori</italic>, whose tetra-acylated lipid A poorly activates the TLR4 complex, failed to trigger the non-canonical inflammasome. Although TLR4 signaling correlates with non-canonical inflammasome activity, this group reported that activation of the non-canonical inflammasome is independent of TLR4 signaling, further suggesting an unknown sensor in the cytosol that detects modified lipid A (<xref ref-type="fig" rid="ppat-1004215-g008"><bold>Figure 8</bold></xref>). We found that caspase-11 expression was essential for IL-1β production elicited by <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub>, pointing to a pivotal role for activation of the non-canonical inflammasome in <italic>P. gingivalis</italic> infection.</p>
<p>Pathogen evasion of inflammasome activation has been proposed to serve a dual role: to prevent IL-1β release and to circumvent host cell death in order to provide an intracellular niche for the pathogen to survive <xref ref-type="bibr" rid="ppat.1004215-Shimada1">[17]</xref>. Indeed, we observed that the low levels of IL-1β induced by <italic>P. gingivalis</italic> strains 381 and <italic>PG1773</italic><sub>381</sub> correlated with an enhanced ability of these organisms to survive in macrophages. Likewise, the induction of relatively high levels of IL-1β by <italic>P. gingivalis</italic> strain <italic>PG1587</italic><sub>381</sub> correlated with decreased survival of this strain in macrophages. The enhanced survival we observed with wild-type 381 and <italic>PG1773</italic><sub>381</sub> are in agreement with our observation that both strains were relatively resistant to killing in the presence of the cationic antimicrobial peptide polymyxin B. In contrast, strain <italic>PG1587</italic><sub>381</sub> was unable to survive intracellularly and was rapidly killed. These results suggest that <italic>P. gingivalis</italic> utilizes multiple mechanisms concurrently to promote its adaptive fitness.</p>
<p>The ability of <italic>P. gingivalis</italic> to survive intracellularly in the macrophage is intriguing when considering the link between periodontal disease and systemic inflammatory conditions. We propose that <italic>P. gingivalis</italic> entry and survival into macrophages may be a mechanism for dissemination of the bacterium from the oral cavity to other systemic sites, such as the vasculature. We have recently identified <italic>P. gingivalis</italic> in blood myeloid dendritic cells of humans with chronic periodontitis, suggesting a role for blood myeloid dendritic cells in harboring and disseminating pathogens from the oral mucosa to atherosclerotic plaques <xref ref-type="bibr" rid="ppat.1004215-Carrion1">[64]</xref>. The mechanism utilized by <italic>P. gingivalis</italic> for survival in myeloid cells remains elusive. Wang et al. <xref ref-type="bibr" rid="ppat.1004215-Wang1">[65]</xref> have shown that intracellular survival of <italic>P. gingivalis</italic> within macrophages is dependent upon TLR2-mediated entry into lipid rafts. Pathogens that hijack lipid rafts do not readily fuse with late endosomes and lysosomes and may potentially fuse to autophagosomes <xref ref-type="bibr" rid="ppat.1004215-Amer1">[66]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Simons1">[67]</xref>. Whether intracellular trafficking to autophagosomes is the mechanism for <italic>P. gingivalis</italic> intracellular survival and dissemination to distant sites remains unknown (<xref ref-type="fig" rid="ppat-1004215-g008"><bold>Figure 8</bold></xref>).</p>
<p>An interesting finding from this study was expression of <italic>P. gingivalis</italic> modified lipid A species did not alter the ability of the organism to induce oral inflammatory bone loss. These results are in agreement with previous studies that show that TLR4 is not needed for the induction of inflammatory bone loss, and it is predominantly mediated via TLR2 signaling <xref ref-type="bibr" rid="ppat.1004215-Hayashi2">[37]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Gibson2">[68]</xref>. We also recently identified a TLR2- and TNF-dependent macrophage-specific mechanism for <italic>P. gingivalis</italic>-induced inflammatory bone loss <italic>in vivo</italic> <xref ref-type="bibr" rid="ppat.1004215-Papadopoulos1">[38]</xref>. In the current study, we observed comparable levels of TNFα were induced in macrophages stimulated with wild-type 381 and the lipid A mutants. In addition to the role of TNFα, it has been recently reported that <italic>P. gingivalis</italic> is able to induce oral bone loss at very low colonization levels, which triggers changes to the amount and composition of the oral commensal microbiota <xref ref-type="bibr" rid="ppat.1004215-Hajishengallis1">[69]</xref>. We have recently demonstrated in a rabbit model of periodontitis that lipid A phosphatases are required for both colonization of the rabbit and increases in the oral microbial load <xref ref-type="bibr" rid="ppat.1004215-Zenobia1">[43]</xref>. Whether this same mechanism for inflammatory bone loss is at play in our study remains to be determined.</p>
<p>It is well established that atherosclerosis progression is due to excessive production of proinflammatory mediators <xref ref-type="bibr" rid="ppat.1004215-Dinarello1">[70]</xref>. Although lipid deposition is considered a leading contributor to the inflammation, additional stimuli, such as infectious agents, have been considered as sources for the continuous inflammation <xref ref-type="bibr" rid="ppat.1004215-Rosenfeld1">[35]</xref>. In our study, we observed infection with <italic>P. gingivalis</italic> induced low levels of proinflammatory mediators but accelerated chronic inflammatory atherosclerosis. Thus, the question arises as to why a pathogen that induces low levels of inflammatory mediators would accelerate chronic inflammatory atherosclerosis. In a recent clinical trial for the inflammasome-mediated disease, Cryopyrin-associated periodic syndrome (CAPS), patients receiving the humanized monoclonal antibody, canakinumab, specific for IL-1β, had a 67% increased risk for infection compared to 25% of patients in the placebo group <xref ref-type="bibr" rid="ppat.1004215-Tabas1">[71]</xref>. This clinical trial supports the results presented in our study that highlight a protective role for activation of innate immunity against low-grade chronic infection. An additional clinical trial was recently launched using canakinumab with the hypothesis that IL-1β inhibition will reduce major cardiovascular events in patients with preexisting coronary artery disease (CAD) <xref ref-type="bibr" rid="ppat.1004215-Ridker1">[72]</xref>. Our results demonstrate that the potential benefit of long-term use of a neutralizing antibody to IL-1β in humans at high risk for atherosclerotic vascular disease must be substantial enough to counter the increased risk of infection <xref ref-type="bibr" rid="ppat.1004215-Tabas1">[71]</xref>. Furthermore, future therapies need to be developed to consider the complexity of inflammatory pathways in chronic inflammation and the role of chronic infection in disease pathology.</p>
</sec></sec><sec id="s3" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s3a">
<title>Ethics statement</title>
<p>This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by Boston University's Institutional Animal Care and Use Committee (IACUC) protocol numbers AN15312 and AN14348. Boston University is committed to observing federal policies and regulations and Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International standards and guidelines for humane care and use of animals. Federal guidelines, the Animal Welfare Act (AWA) and The Guide were followed when carrying out experiments. Procedures involved euthanasia and harvesting of bone marrow macrophages. All efforts were made to minimize discomfort, pain and distress.</p>
</sec><sec id="s3b">
<title>Bacteria</title>
<p>Frozen stocks of <italic>P. gingivalis</italic> wild-type strain 381 and the lipid A mutants (<italic>PG1587</italic><sub>381</sub> and <italic>PG1773</italic><sub>381</sub>) were grown anaerobically at 37°C on blood agar plates (Remel) for 3–5 days <xref ref-type="bibr" rid="ppat.1004215-Takahashi1">[73]</xref>. Brain heart infusion broth (Becton-Dickinson Biosciences) supplemented with yeast extract (0.5%; Becton-Dickinson Biosciences), hemin (10 µg/ml; Sigma-Aldrich), and menadione (1 mg/ml; Sigma- Aldrich) was inoculated with plate grown bacteria and cultures grown anaerobically for 16–18 h. <italic>P. gingivalis</italic> lipid A mutants were grown in the presence of erythromycin (5 µg/mL).</p>
</sec><sec id="s3c">
<title>Gene deletions in <italic>P. gingivalis</italic> strain 381</title>
<p>The genomic nucleotide sequences encoding the putative lipid A 1-phosphatase, <italic>PG1773</italic>, and the putative lipid A 4′-phosphatase, <italic>PG1587</italic>, were obtained from searches of the annotated <italic>P. gingivalis</italic> W83 genome at The Comprehensive Microbial Resource (<ext-link ext-link-type="uri" xlink:href="http://cmr.jcvi.org/tigr-scripts/CMR/CmrHomePage.cgi" xlink:type="simple">http://cmr.jcvi.org/tigr-scripts/CMR/CmrHomePage.cgi</ext-link>). Gene deletions were created by introducing an erythromycin resistance cassette (<italic>ermF/AM</italic>) in place of the coding region for <italic>PG1773</italic> and <italic>PG1587</italic>. Polymerase chain reaction (PCR) amplification of genomic DNA from <italic>P. gingivalis</italic> 381 was performed using primer sets designed against the W83 sequence to amplify 1000 base-pairs upstream and 1000 base-pairs downstream from the regions adjacent to the <italic>PG1773</italic> and <italic>PG1587</italic> coding regions, respectively. The amplified 5′ and 3′ flanking regions for <italic>PG1773</italic> and <italic>PG1587</italic>, respectively, were co-ligated with the <italic>ermF/AM</italic> cassettes respectively into pcDNA3.1(−) to generate the gene disruption plasmids, p1773 5′flank:erm:3′flank and p1587 5′flank:erm:3′flank. <italic>P. gingivalis</italic> 381 deficient in either <italic>PG1587</italic> (<italic>PG1587</italic><sub>381</sub>) or <italic>PG1773</italic> (<italic>PG1773</italic><sub>381</sub>) was generated by introducing either p1587 5′flank:erm:3′flank or p1773 5′flank:erm:3′flank into <italic>P. gingivalis</italic> 381 by electroporation in a GenePulser Xcell (BioRad, Hercules, CA). Bacteria were plated on TYHK/agar plates containing the appropriate selective medium, which included erythromycin (5 µg/ml), and incubated anaerobically. One week later, colonies were selected for characterization. Loss of the <italic>PG1587</italic> and <italic>PG1773</italic> coding sequences were confirmed in all clones by PCR analyses using primers designed to detect the coding sequences in wild-type 381 bacteria.</p>
</sec><sec id="s3d">
<title>MALDI-TOF MS analyses</title>
<p>LPS and Lipid A from <italic>P. gingivalis</italic> 381 and the lipid A mutant strains (<italic>PG1587</italic><sub>381</sub> and <italic>PG1773</italic><sub>381</sub>) were isolated as previously described <xref ref-type="bibr" rid="ppat.1004215-Coats3">[23]</xref>. For MALDI-TOF MS analyses, lipid A were analyzed in the negative ion mode on an AutoFlex Analyzer (Bruker Daltonics). Data were acquired and processed using Flex Analysis software (Bruker Daltonics) <xref ref-type="bibr" rid="ppat.1004215-Coats1">[6]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Coats3">[23]</xref>.</p>
</sec><sec id="s3e">
<title>HEK293 cell TLR activation assays</title>
<p>HEK293 cells were plated in 96-well plates at a density of 4×10<sup>4</sup> cells per well, and transfected the following day with plasmids bearing firefly luciferase, <italic>Renilla</italic> luciferase, recombinant murine TLR4 and MD-2 or recombinant murine TLR2 and TLR1 by standard calcium phosphate precipitation. After overnight transfection, the test wells were stimulated in triplicate for 4 hours at 37°C with the indicated doses of LPS isolates or live bacteria. Following stimulation, the transfected HEK293 cells were rinsed with phosphate-buffered saline and lysed with 50 µl of passive lysis buffer (Promega, Madison, WI). Luciferase activity was measured using the Dual Luciferase Assay Reporter System (Promega, Madison, WI). Data are expressed as fold increase of NF-κB-activity which represents the ratio of NF-κB-dependent fire-fly luciferase activity to β-Actin promoter-dependent <italic>Renilla</italic> luciferase activity.</p>
</sec><sec id="s3f">
<title>Polymyxin B sensitivity assays</title>
<p>BHI broth cultures of wild-type 381 and the lipid A mutant strains were started at an optical density of .1 at 660 nm in the presence or absence of increasing concentrations (1, 5, 10, 25, 50 µg/mL) of polymxin B (InvivoGen). After overnight growth under anaerobic conditions, growth was assessed spectrophotometrically at 660 nm <xref ref-type="bibr" rid="ppat.1004215-Coats5">[74]</xref>.</p>
</sec><sec id="s3g">
<title>Animals</title>
<p>Male ApoE<sup>−/−</sup> and C57BL/6 mice were obtained from The Jackson Laboratory (Bar Harbor, ME). C57BL/6 mice deficient in TLR2 and TLR4 were provided by Dr. S. Akira (Osaka University, Osaka, Japan) and bred in house. Mice were maintained under specific-pathogen free conditions and cared for in accordance with the Boston University Institutional Animal Care and Use Committee.</p>
</sec><sec id="s3h">
<title>Bone marrow derived macrophage culture and stimulation</title>
<p>Bone marrow derived macrophages (BMDM) from wild-type and knockout mice were cultured in RPMI with 10% fetal bovine serum (Thermo Scientific HyClone Fetal Bovine Serum (U.S.), Defined SH3007003HI Heat inactivated) and 20% L929 supernatants <xref ref-type="bibr" rid="ppat.1004215-Rathinam1">[49]</xref> and were allowed to mature into macrophages over 7 days. Cells were seeded into 24-well plates at 2×10<sup>5</sup> cells/well (ELISA assays) or 6-well plates at 1×10<sup>6</sup> cells/well (Western blot analysis) and stimulated with bacteria at indicated MOI overnight. Cells stimulated with LPS from <italic>E. coli</italic> OIII:B4 (InvivoGen) or Pam3CysSk4 (InvivoGen) served as controls.</p>
</sec><sec id="s3i">
<title>ELISA</title>
<p>Levels of IL-1β, TNFα, IL-6 (BD Bioscience), IL-1α (eBioscience) and KC (R&amp;D Systems) in cell culture supernatants were analyzed by ELISA.</p>
</sec><sec id="s3j">
<title>Immunoblotting</title>
<p>Proteins from cell culture supernatants were precipitated with ethanol at −20°C overnight and resuspended in Laemmli sample buffer. Cellular lysates were collected in RIPA buffer (Thermo Scientific) and samples were prepared in Laemmli sample buffer. Samples were separated by SDS-PAGE, transferred to polyvinyldifluoride membranes, blocked in 5% milk and target proteins were detected using antibodies to IL-1β (H-153) and caspase-1 p10 (M-20) (Santa Cruz Biotechnology). An antibody to β-actin (A1978 Sigma) was used as the loading control.</p>
</sec><sec id="s3k">
<title>Antibiotic protection assay</title>
<p>BMDM were stimulated with <italic>P. gingivalis</italic> or lipid A mutants for 2 h and 6 h. Extracellular nonadherent bacteria were removed by washing with PBS. Adherent bacteria were killed by addition of gentamicin (300 µg/mL) and metronidazole (200 µg/mL) for 1 hr. After PBS wash, BMDM were lysed with HyClone water (Thermo Scientific) for 10 min. Serial dilutions of the lysate were plated on blood agar plates and cultured anaerobically for CFU enumeration <xref ref-type="bibr" rid="ppat.1004215-Wang1">[65]</xref>.</p>
</sec><sec id="s3l">
<title>Oral challenge</title>
<p>Mice were fed a normal chow diet (Global 2018; Harlan Teklad, Madison, WI). Six-week old male mice were treated with a 10-day regimen of oral antibiotics to allow for <italic>P. gingivalis</italic> colonization. Mice were challenged by oral application of vehicle (2% carboxymethylcellulose in PBS) or the <italic>P. gingivalis</italic> strains (1×10<sup>9</sup> CFU) at the buccal surface of the maxilla 5 times a week for 3 weeks <xref ref-type="bibr" rid="ppat.1004215-Gibson1">[36]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Hayashi2">[37]</xref>.</p>
</sec><sec id="s3m">
<title><italic>In vivo</italic> mouse Magnetic Resonance Angiography (MRA) and data analysis</title>
<p><italic>In vivo</italic> imaging of the innominate artery was performed using a vertical-bore Bruker 11.7 T Avance spectrometer (Bruker; Billerica, MA) as previously described <xref ref-type="bibr" rid="ppat.1004215-Hayashi4">[53]</xref>. Mice were anesthetized with 0.5–2% inhaled isoflurane and placed in a vertical 30 mm probe (Micro 2.5). Respiration was monitored using a small animal monitoring and gating system (SA Instruments, Waukesha, WI). The angiography data was acquired with a fast low-angle shot (FLASH) sequence using the following parameters: slab thickness = 1.5 cm; flip angle = 45°; repetition time = 20 ms; echo time = 2.2 ms; field of view = 1.5×1.5×1.5 cm; matrix = 128×128×128; number of average = 4. The total scan time was ∼25 min. Visualization of the vasculature was achieved by 3D maximum intensity projections (MIP) of angiographic images reconstructed using Paravision. The target cross section of the innominate artery was chosen at 0.3- to 0.5-mm distance below the subclavian bifurcation. Lumen area of the chosen cross section was manually defined and calculated with ImageJ (National Institutes of Health) by two independent observers. The intra-reader reliability was excellent with interclass correlation coefficient values of 0.91.</p>
</sec><sec id="s3n">
<title>Immunohistochemistry</title>
<p>Mice were euthanized (n = 3–4/group), perfused with PBS (5 mL) and the aortic arch with heart tissue was embedded in OCT freezing compound. Seven-micrometer serial cryosections were collected every 70 µm in the innominate artery. Immunohistochemistry was performed on cryosections corresponding to greatest plaque accumulation in the innominate artery as previously described <xref ref-type="bibr" rid="ppat.1004215-Hayashi3">[42]</xref>, <xref ref-type="bibr" rid="ppat.1004215-Hayashi4">[53]</xref> using rat anti-mouse F4/80 (no. MCA497R; Serotec, Oxford, U.K.) or isotype controls (no. MCA1125; Serotec). Biotinylated anti-rat (mouse absorbed) IgG was used as secondary Ab (Vector Laboratories, Burlin- game, CA). Nuclei were counter-stained with hematoxylin. Digital micrographs were captured at 10× and 40×.</p>
</sec><sec id="s3o">
<title>Atherosclerotic plaque assessment</title>
<p>Aortas were harvested and stained with Oil Red O as described <xref ref-type="bibr" rid="ppat.1004215-Hayashi3">[42]</xref>. Digital micrographs were taken, and total area of atherosclerotic plaque was determined using ImageJ (NIH) by a blinded observer.</p>
</sec><sec id="s3p">
<title>Microcomputed tomography</title>
<p>Three-dimensional analysis of alveolar bone loss was assessed as previously described <xref ref-type="bibr" rid="ppat.1004215-Papadopoulos1">[38]</xref>. Briefly, cephalons were fixed for 24–48 h in 4% buffered paraformaldehyde and stored at 4°C in 70% ethanol until evaluation by microcomputed tomography (micro-CT). Quantitative three-dimensional analysis of alveolar bone loss in hemi-maxillae was performed using a desktop micro-CT system (μCT 40; Scanco Medical AG, Bassersdorf, Switzerland). Maxillary block biopsies were scanned at a resolution of 12 µm in all three spatial dimensions. Raw images were converted into high-quality dicoms and analyzed using computer software (Amira 5.2.2; Visage Imaging). Residual supporting bone volume was determined for the buccal roots. The apical basis of the measured volume was set mesio-distally parallel to the cemento-enamel junction and bucco-palatinally parallel to the occlusal plane. Results represent residual bone volume (mm<sup>3</sup>) above the reference plane (180 µm from the cemento-enamel junction).</p>
</sec><sec id="s3q">
<title>Statistical analysis</title>
<p>Data were analyzed by two-tailed unpaired Student's t test or ANOVA with Bonferroni's posttest where indicated. A p value of .05 was considered indicative of statistical significance.</p>
</sec></sec><sec id="s4">
<title>Supporting Information</title>
<supplementary-material id="ppat.1004215.s001" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.ppat.1004215.s001" position="float" xlink:type="simple"><label>Figure S1</label><caption>
<p><bold>Fimbriae expression, gingipain activity, and growth of </bold><bold><italic>P. gingivalis</italic></bold><bold> lipid A 1- and 4′ phosphatase mutants.</bold> Electron microscopy was performed with <italic>P. gingivalis</italic> wild-type strain 381, <italic>PG1587</italic><sub>381</sub> and <italic>PG1773</italic><sub>381</sub> (<bold>A</bold>). Fimbriae expression was examined by Western blot analysis in whole cell lysates (5×10<sup>7</sup> CFU) using a monoclonal Ab to major fimbriae (<bold>B</bold>) <xref ref-type="bibr" rid="ppat.1004215-Takahashi1">[73]</xref>. The proteolytic activities of the cell-associated cysteine proteases, gingipain R (<bold>RGP</bold>) and gingipain K (<bold>KGP</bold>) for wild-type 381 and the lipid A mutants <italic>PG1587</italic><sub>381</sub> and <italic>PG1773</italic><sub>381</sub> in whole cultures (lysate) and supernatant fractions were determined by an <italic>in vitro</italic> gingipain assay <xref ref-type="bibr" rid="ppat.1004215-Madrigal1">[75]</xref> (<bold>C</bold>). Percent proteolytic activity as compared to <italic>P. gingivalis</italic> wild-type strain 381 gingipain activity for <italic>PG1587</italic><sub>381</sub> (<bold>dotted</bold>) and <italic>PG1773</italic><sub>381</sub> (<bold>dashed</bold>). Bars indicate mean ± SEM from three independent experiments. Brain heart infusion broth cultures of <italic>P. gingivalis</italic> wild-type (<bold>solid</bold>), <italic>PG1587</italic><sub>381</sub> (<bold>dotted</bold>), and <italic>PG1773</italic><sub>381</sub> (<bold>dashed</bold>) were inoculated at a starting OD of 0.3. Growth was monitored at indicated time points over 48 h (n = 4) (<bold>D</bold>).</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="ppat.1004215.s002" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.ppat.1004215.s002" position="float" xlink:type="simple"><label>Figure S2</label><caption>
<p><bold>TLR2 and TLR4 contribute to the production of IL-1β and IL-1α in macrophages stimulated with </bold><bold><italic>P. gingivalis</italic></bold><bold> wild-type strain 381 and the lipid A mutant strains.</bold> BMDMs from wild-type C57BL/6 (<bold>white</bold>), TLR2-deficient (<bold>gray</bold>), or TLR4-deficient mice (<bold>black</bold>) were stimulated with <italic>P. gingivalis</italic> wild-type strain 381 or the lipid A mutant strains <italic>PG1587</italic><sub>381</sub> and <italic>PG1773</italic><sub>381</sub> at an MOI of 100 and levels of IL-1β (<bold>A</bold>) and IL-1α (<bold>B</bold>) were assessed by ELISA. Bars indicate mean ± SEM for n = 3 sample wells. *p&lt;.05 **p&lt;.01; two-tailed unpaired t-tests.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="ppat.1004215.s003" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.ppat.1004215.s003" position="float" xlink:type="simple"><label>Figure S3</label><caption>
<p><bold>Plaque accumulation in the innominate artery following oral infection of ApoE<sup>−/−</sup> mice with </bold><bold><italic>P. gingivalis</italic></bold><bold>.</bold> Representative images of the innominate artery with hematoxylin and eosin staining for each group at 10× and 40× (n = 3/group).</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="ppat.1004215.s004" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.ppat.1004215.s004" position="float" xlink:type="simple"><label>Figure S4</label><caption>
<p><bold>Humoral response following oral infection of ApoE<sup>−/−</sup> mice with </bold><bold><italic>P. gingivalis.</italic></bold><italic> P. gingivalis</italic>-specific Ab isotypes IgG1 (<bold>A</bold>), IgG2b (<bold>B</bold>), IgG2c (<bold>C</bold>) and IgG3 (<bold>D</bold>) were measured in serum by ELISA at 16 wk post-infection of ApoE<sup>−/−</sup> mice with <italic>P. gingivalis</italic> wild-type strain 381 and the lipid A mutants <italic>PG1587</italic><sub>381</sub> and <italic>PG1773</italic><sub>381</sub> (n = 10–12 mice/group). * p&lt;.05 **p≤.001; two-tailed unpaired t-tests.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="ppat.1004215.s005" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xlink:href="info:doi/10.1371/journal.ppat.1004215.s005" position="float" xlink:type="simple"><label>Text S1</label><caption>
<p><bold>Supporting information on experimental procedures.</bold> Describes the experimental procedures utilized for the supplemental data. This includes experimental procedures for Electron Microscopy, Gingipain Assay, ELISA, and Histology.</p>
<p>(DOCX)</p>
</caption></supplementary-material></sec></body>
<back>
<ack>
<p>From Boston University School of Medicine, we acknowledge Dr. Xuemei Zhong and Natalie Bitar (Immunohistochemistry Core), Aaron Brug and Dr. Heidi Schwanz (Magnetic Resonance Imaging), and Dr. Esther Bullitt (Electron Microscopy) for their technical assistance. We thank Dr. Katherine A. Fitzgerald (University of Massachusetts Medical School, Worcester, MA) for providing C57BL/6 mice deficient in caspase-11.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ppat.1004215-Akira1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Akira</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Takeda</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kaisho</surname><given-names>T</given-names></name> (<year>2001</year>) <article-title>Toll-like receptors: critical proteins linking innate and acquired immunity</article-title>. <source>Nat Immunol</source> <volume>2</volume>: <fpage>675</fpage>–<lpage>680</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/90609" xlink:type="simple">10.1038/90609</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Munford1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Munford</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Varley</surname><given-names>AW</given-names></name> (<year>2006</year>) <article-title>Shield as signal: lipopolysaccharides and the evolution of immunity to gram-negative bacteria</article-title>. <source>PLoS Pathog</source> <volume>2</volume>: <fpage>e67</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.0020067" xlink:type="simple">10.1371/journal.ppat.0020067</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Miller1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miller</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Ernst</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Bader</surname><given-names>MW</given-names></name> (<year>2005</year>) <article-title>LPS, TLR4 and infectious disease diversity</article-title>. <source>Nat Rev Micro</source> <volume>3</volume>: <fpage>36</fpage>–<lpage>46</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrmicro1068" xlink:type="simple">10.1038/nrmicro1068</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Needham1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Needham</surname><given-names>BD</given-names></name>, <name name-style="western"><surname>Trent</surname><given-names>MS</given-names></name> (<year>2013</year>) <article-title>Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis</article-title>. <source>Nat Rev Micro</source> <volume>11</volume>: <fpage>467</fpage>–<lpage>481</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrmicro3047" xlink:type="simple">10.1038/nrmicro3047</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Raetz1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raetz</surname><given-names>CRH</given-names></name>, <name name-style="western"><surname>Whitfield</surname><given-names>C</given-names></name> (<year>2002</year>) <article-title>Lipopolysaccharide endotoxins</article-title>. <source>Annu Rev Biochem</source> <volume>71</volume>: <fpage>635</fpage>–<lpage>700</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1146/annurev.biochem.71.110601.135414" xlink:type="simple">10.1146/annurev.biochem.71.110601.135414</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Coats1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Coats</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Berezow</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>To</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bainbridge</surname><given-names>BW</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>The lipid A phosphate position determines differential host Toll-like receptor 4 responses to phylogenetically related symbiotic and pathogenic bacteria</article-title>. <source>Infection and Immunity</source> <volume>79</volume>: <fpage>203</fpage>–<lpage>210</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.00937-10" xlink:type="simple">10.1128/IAI.00937-10</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Cullen1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cullen</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Giles</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>LN</given-names></name>, <name name-style="western"><surname>Ecobichon</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Boneca</surname><given-names>IG</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Helicobacter pylori versus the host: remodeling of the bacterial outer membrane is required for survival in the gastric mucosa</article-title>. <source>PLoS Pathog</source> <volume>7</volume>: <fpage>e1002454</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1002454" xlink:type="simple">10.1371/journal.ppat.1002454</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Neumeister1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Neumeister</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Faigle</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sommer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zähringer</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Stelter</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Low endotoxic potential of Legionella pneumophila lipopolysaccharide due to failure of interaction with the monocyte lipopolysaccharide receptor CD14</article-title>. <source>Infection and Immunity</source> <volume>66</volume>: <fpage>4151</fpage>–<lpage>4157</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004215-Kawahara1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kawahara</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tsukano</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lindner</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Matsuura</surname><given-names>M</given-names></name> (<year>2002</year>) <article-title>Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature</article-title>. <source>Infection and Immunity</source> <volume>70</volume>: <fpage>4092</fpage>–<lpage>4098</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004215-Hajjar1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hajjar</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Harvey</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Shaffer</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Goodlett</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Sjöstedt</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors</article-title>. <source>Infection and Immunity</source> <volume>74</volume>: <fpage>6730</fpage>–<lpage>6738</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.00934-06" xlink:type="simple">10.1128/IAI.00934-06</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Rebeil1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rebeil</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ernst</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Jarrett</surname><given-names>CO</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>KN</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>SI</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Characterization of late acyltransferase genes of Yersinia pestis and their role in temperature-dependent lipid A variation</article-title>. <source>J Bacteriol</source> <volume>188</volume>: <fpage>1381</fpage>–<lpage>1388</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JB.188.4.1381-1388.2006" xlink:type="simple">10.1128/JB.188.4.1381-1388.2006</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Li1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Powell</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Shaffer</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Rasko</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Pelletier</surname><given-names>MR</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>LPS remodeling is an evolved survival strategy for bacteria</article-title>. <source>PNAS</source> <volume>109</volume>: <fpage>8716</fpage>–<lpage>8721</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1202908109" xlink:type="simple">10.1073/pnas.1202908109</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Maeshima1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maeshima</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Fernandez</surname><given-names>RC</given-names></name> (<year>2013</year>) <article-title>Recognition of lipid A variants by the TLR4-MD-2 receptor complex</article-title>. <source>Front Cell Infect Microbiol</source> <volume>3</volume>: <fpage>3</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fcimb.2013.00003" xlink:type="simple">10.3389/fcimb.2013.00003</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Kayagaki1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kayagaki</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Stowe</surname><given-names>IB</given-names></name>, <name name-style="western"><surname>Ramani</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>LC</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4</article-title>. <source>Science</source> <volume>341</volume>: <fpage>1246</fpage>–<lpage>1249</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1240248" xlink:type="simple">10.1126/science.1240248</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Franchi1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Franchi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Eigenbrod</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Muñoz-Planillo</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nuñez</surname><given-names>G</given-names></name> (<year>2009</year>) <article-title>The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis</article-title>. <source>Nat Immunol</source> <volume>10</volume>: <fpage>241</fpage>–<lpage>247</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ni.1703" xlink:type="simple">10.1038/ni.1703</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Taxman1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Taxman</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>MT-H</given-names></name>, <name name-style="western"><surname>Ting</surname><given-names>JPY</given-names></name> (<year>2010</year>) <article-title>Inflammasome inhibition as a pathogenic stealth mechanism</article-title>. <source>Cell Host Microbe</source> <volume>8</volume>: <fpage>7</fpage>–<lpage>11</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.chom.2010.06.005" xlink:type="simple">10.1016/j.chom.2010.06.005</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Shimada1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shimada</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Crother</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Karlin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dagvadorj</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chiba</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis</article-title>. <source>Immunity</source> <volume>36</volume>: <fpage>401</fpage>–<lpage>414</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.immuni.2012.01.009" xlink:type="simple">10.1016/j.immuni.2012.01.009</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Bainbridge1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bainbridge</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>Coats</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Darveau</surname><given-names>RP</given-names></name> (<year>2002</year>) <article-title>Porphyromonas gingivalis lipopolysaccharide displays functionally diverse interactions with the innate host defense system</article-title>. <source>Ann Periodontol</source> <volume>7</volume>: <fpage>29</fpage>–<lpage>37</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1902/annals.2002.7.1.29" xlink:type="simple">10.1902/annals.2002.7.1.29</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Kumada1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kumada</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Haishima</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Umemoto</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tanamoto</surname><given-names>K</given-names></name> (<year>1995</year>) <article-title>Structural study on the free lipid A isolated from lipopolysaccharide of Porphyromonas gingivalis</article-title>. <source>J Bacteriol</source> <volume>177</volume>: <fpage>2098</fpage>–<lpage>2106</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004215-Coats2"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Coats</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Pham</surname><given-names>T-TT</given-names></name>, <name name-style="western"><surname>Bainbridge</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>Reife</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Darveau</surname><given-names>RP</given-names></name> (<year>2005</year>) <article-title>MD-2 mediates the ability of tetra-acylated and penta-acylated lipopolysaccharides to antagonize Escherichia coli lipopolysaccharide at the TLR4 signaling complex</article-title>. <source>J Immunol</source> <volume>175</volume>: <fpage>4490</fpage>–<lpage>4498</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004215-Reife1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reife</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Coats</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Al-Qutub</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dixon</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Braham</surname><given-names>PA</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Porphyromonas gingivalis lipopolysaccharide lipid A heterogeneity: differential activities of tetra- and penta-acylated lipid A structures on E-selectin expression and TLR4 recognition</article-title>. <source>Cellular Microbiology</source> <volume>8</volume>: <fpage>857</fpage>–<lpage>868</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1462-5822.2005.00672.x" xlink:type="simple">10.1111/j.1462-5822.2005.00672.x</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-AlQutub1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Al-Qutub</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Braham</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Karimi-Naser</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Genco</surname><given-names>CA</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Hemin-Dependent Modulation of the Lipid A Structure of Porphyromonas gingivalis Lipopolysaccharide</article-title>. <source>Infection and Immunity</source> <volume>74</volume>: <fpage>4474</fpage>–<lpage>4485</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.01924-05" xlink:type="simple">10.1128/IAI.01924-05</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Coats3"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Coats</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Do</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Braham</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Bainbridge</surname><given-names>BW</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Human Toll-like receptor 4 responses to P. gingivalisare regulated by lipid A 1- and 4′-phosphatase activities</article-title>. <source>Cellular Microbiology</source> <volume>11</volume>: <fpage>1587</fpage>–<lpage>1599</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1462-5822.2009.01349.x" xlink:type="simple">10.1111/j.1462-5822.2009.01349.x</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Curtis1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Curtis</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Percival</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Devine</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Darveau</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Coats</surname><given-names>SR</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Temperature-dependent modulation of Porphyromonas gingivalis lipid A structure and interaction with the innate host defenses</article-title>. <source>Infection and Immunity</source> <volume>79</volume>: <fpage>1187</fpage>–<lpage>1193</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.00900-10" xlink:type="simple">10.1128/IAI.00900-10</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Rangarajan1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rangarajan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Aduse-Opoku</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Paramonov</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hashim</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bostanci</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Identification of a second lipopolysaccharide in Porphyromonas gingivalis W50</article-title>. <source>J Bacteriol</source> <volume>190</volume>: <fpage>2920</fpage>–<lpage>2932</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JB.01868-07" xlink:type="simple">10.1128/JB.01868-07</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Herath1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Herath</surname><given-names>TDK</given-names></name>, <name name-style="western"><surname>Darveau</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Seneviratne</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C-Y</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-κB signal transduction cascade and immuno-inflammatory response in human gingival fibroblasts</article-title>. <source>PLoS ONE</source> <volume>8</volume>: <fpage>e58496</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0058496" xlink:type="simple">10.1371/journal.pone.0058496</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Hayashi1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hayashi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gudino</surname><given-names>CV</given-names></name>, <name name-style="western"><surname>Gibson</surname><given-names>FC</given-names><suffix>III</suffix></name>, <name name-style="western"><surname>Genco</surname><given-names>CA</given-names></name> (<year>2010</year>) <article-title>REVIEW: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways</article-title>. <source>Mol Oral Microbiol</source> <volume>25</volume>: <fpage>305</fpage>–<lpage>316</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.2041-1014.2010.00582.x" xlink:type="simple">10.1111/j.2041-1014.2010.00582.x</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Oliver1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oliver</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Löe</surname><given-names>H</given-names></name> (<year>1998</year>) <article-title>Periodontal diseases in the United States population</article-title>. <source>J Periodontol</source> <volume>69</volume>: <fpage>269</fpage>–<lpage>278</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004215-Pihlstrom1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pihlstrom</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Michalowicz</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>NW</given-names></name> (<year>2005</year>) <article-title>Periodontal diseases</article-title>. <source>Lancet</source> <volume>366</volume>: <fpage>1809</fpage>–<lpage>1820</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(05)67728-8" xlink:type="simple">10.1016/S0140-6736(05)67728-8</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Bohnstedt1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bohnstedt</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cullinan</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Ford</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Palmer</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Leishman</surname><given-names>SJ</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>High antibody levels to P. gingivalis in cardiovascular disease</article-title>. <source>Journal of Dental Research</source> <volume>89</volume>: <fpage>938</fpage>–<lpage>942</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/0022034510370817" xlink:type="simple">10.1177/0022034510370817</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Tonetti1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tonetti</surname><given-names>MS</given-names></name> (<year>2009</year>) <article-title>Periodontitis and risk for atherosclerosis: an update on intervention trials</article-title>. <source>J Clin Periodontol</source> <volume>36</volume> (<issue>Suppl 10</issue>) <fpage>15</fpage>–<lpage>19</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1600-051X.2009.01417.x" xlink:type="simple">10.1111/j.1600-051X.2009.01417.x</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Michaud1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Michaud</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Izard</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wilhelm-Benartzi</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>You</surname><given-names>D-H</given-names></name>, <name name-style="western"><surname>Grote</surname><given-names>VA</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study</article-title>. <source>Gut</source> <volume>62</volume>: <fpage>1764</fpage>–<lpage>1770</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/gutjnl-2012-303006" xlink:type="simple">10.1136/gutjnl-2012-303006</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Haraszthy1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haraszthy</surname><given-names>VI</given-names></name>, <name name-style="western"><surname>Zambon</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Trevisan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zeid</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Genco</surname><given-names>RJ</given-names></name> (<year>2000</year>) <article-title>Identification of periodontal pathogens in atheromatous plaques</article-title>. <source>J Periodontol</source> <volume>71</volume>: <fpage>1554</fpage>–<lpage>1560</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1902/jop.2000.71.10.1554" xlink:type="simple">10.1902/jop.2000.71.10.1554</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Kozarov1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kozarov</surname><given-names>EV</given-names></name>, <name name-style="western"><surname>Dorn</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Shelburne</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Dunn</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Progulske-Fox</surname><given-names>A</given-names></name> (<year>2005</year>) <article-title>Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis</article-title>. <source>Arteriosclerosis, Thrombosis, and Vascular Biology</source> <volume>25</volume>: <fpage>e17</fpage>–<lpage>e18</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/01.ATV.0000155018.67835.1a" xlink:type="simple">10.1161/01.ATV.0000155018.67835.1a</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Rosenfeld1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rosenfeld</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>LA</given-names></name> (<year>2011</year>) <article-title>Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis</article-title>. <source>Thromb Haemost</source> <volume>106</volume>: <fpage>858</fpage>–<lpage>867</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1160/TH11-06-0392" xlink:type="simple">10.1160/TH11-06-0392</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Gibson1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gibson</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chou</surname><given-names>H-H</given-names></name>, <name name-style="western"><surname>Yumoto</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice</article-title>. <source>Circulation</source> <volume>109</volume>: <fpage>2801</fpage>–<lpage>2806</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/01.CIR.0000129769.17895.F0" xlink:type="simple">10.1161/01.CIR.0000129769.17895.F0</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Hayashi2"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hayashi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Madrigal</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Ukai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Goswami</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses</article-title>. <source>J Innate Immun</source> <volume>2</volume>: <fpage>334</fpage>–<lpage>343</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000314686" xlink:type="simple">10.1159/000314686</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Papadopoulos1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Papadopoulos</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Weinberg</surname><given-names>EO</given-names></name>, <name name-style="western"><surname>Massari</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gibson</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Wetzler</surname><given-names>LM</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss</article-title>. <source>The Journal of Immunology</source> <volume>190</volume>: <fpage>1148</fpage>–<lpage>1157</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.1202511" xlink:type="simple">10.4049/jimmunol.1202511</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Jain1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jain</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Coats</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Darveau</surname><given-names>RP</given-names></name> (<year>2013</year>) <article-title>A Novel Class of Lipoprotein Lipase-Sensitive Molecules Mediates Toll-Like Receptor 2 Activation by Porphyromonas gingivalis</article-title>. <source>Infection and Immunity</source> <volume>81</volume>: <fpage>1277</fpage>–<lpage>1286</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.01036-12" xlink:type="simple">10.1128/IAI.01036-12</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Davey1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davey</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Ukai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Gudino</surname><given-names>CV</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Bacterial Fimbriae Stimulate Proinflammatory Activation in the Endothelium through Distinct TLRs</article-title>. <source>The Journal of Immunology</source> <volume>180</volume>: <fpage>2187</fpage>–<lpage>2195</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004215-Nichols1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nichols</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Bajrami</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Housley</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>X</given-names></name> (<year>2012</year>) <article-title>Free Lipid A Isolated from Porphyromonas gingivalis Lipopolysaccharide Is Contaminated with Phosphorylated Dihydroceramide Lipids: Recovery in Diseased Dental Samples</article-title>. <source>Infection and Immunity</source> <volume>80</volume>: <fpage>860</fpage>–<lpage>874</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.06180-11" xlink:type="simple">10.1128/IAI.06180-11</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Hayashi3"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hayashi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Papadopoulos</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Gudino</surname><given-names>CV</given-names></name>, <name name-style="western"><surname>Weinberg</surname><given-names>EO</given-names></name>, <name name-style="western"><surname>Barth</surname><given-names>KR</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Protective Role for TLR4 Signaling in Atherosclerosis Progression as Revealed by Infection with a Common Oral Pathogen</article-title>. <source>The Journal of Immunology</source> <volume>189</volume>: <fpage>3681</fpage>–<lpage>3688</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.1201541" xlink:type="simple">10.4049/jimmunol.1201541</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Zenobia1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zenobia</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hasturk</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Van Dyke</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Kantarci</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Porphyromonas gingivalis Lipid A Phosphatase Activity Is Critical for Colonization and Increasing the Commensal Load in the Rabbit Ligature Model</article-title>. <source>Infection and Immunity</source> <volume>82</volume>: <fpage>650</fpage>–<lpage>659</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.01136-13" xlink:type="simple">10.1128/IAI.01136-13</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Tschopp1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tschopp</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Martinon</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Burns</surname><given-names>K</given-names></name> (<year>2003</year>) <article-title>NALPs: a novel protein family involved in inflammation</article-title>. <source>Nat Rev Mol Cell Biol</source> <volume>4</volume>: <fpage>95</fpage>–<lpage>104</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrm1019" xlink:type="simple">10.1038/nrm1019</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Bostanci1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bostanci</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Allaker</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Belibasakis</surname><given-names>GN</given-names></name>, <name name-style="western"><surname>Rangarajan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Curtis</surname><given-names>MA</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Porphyromonas gingivalis antagonises Campylobacter rectus induced cytokine production by human monocytes</article-title>. <source>Cytokine</source> <volume>39</volume>: <fpage>147</fpage>–<lpage>156</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cyto.2007.07.002" xlink:type="simple">10.1016/j.cyto.2007.07.002</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Taxman2"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Taxman</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Swanson</surname><given-names>KV</given-names></name>, <name name-style="western"><surname>Broglie</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Wen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Holley-Guthrie</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Porphyromonas gingivalis Mediates Inflammasome Repression in Polymicrobial Cultures through a Novel Mechanism Involving Reduced Endocytosis</article-title>. <source>Journal of Biological Chemistry</source> <volume>287</volume>: <fpage>32791</fpage>–<lpage>32799</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M112.401737" xlink:type="simple">10.1074/jbc.M112.401737</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Mariathasan1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mariathasan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Monack</surname><given-names>DM</given-names></name> (<year>2007</year>) <article-title>Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation</article-title>. <source>Nat Rev Immunol</source> <volume>7</volume>: <fpage>31</fpage>–<lpage>40</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nri1997" xlink:type="simple">10.1038/nri1997</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Kayagaki2"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kayagaki</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Warming</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lamkanfi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Vande Walle</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Louie</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Non-canonical inflammasome activation targets caspase-11</article-title>. <source>Nature</source> <volume>479</volume>: <fpage>117</fpage>–<lpage>121</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature10558" xlink:type="simple">10.1038/nature10558</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Rathinam1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rathinam</surname><given-names>VAK</given-names></name>, <name name-style="western"><surname>Vanaja</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Waggoner</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sokolovska</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Becker</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria</article-title>. <source>Cell</source> <volume>150</volume>: <fpage>606</fpage>–<lpage>619</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cell.2012.07.007" xlink:type="simple">10.1016/j.cell.2012.07.007</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Broz1"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Broz</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Monack</surname><given-names>DM</given-names></name> (<year>2013</year>) <article-title>Noncanonical inflammasomes: caspase-11 activation and effector mechanisms</article-title>. <source>PLoS Pathog</source> <volume>9</volume>: <fpage>e1003144</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1003144" xlink:type="simple">10.1371/journal.ppat.1003144</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Baker1"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baker</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Roopenian</surname><given-names>DC</given-names></name> (<year>1994</year>) <article-title>Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice</article-title>. <source>Arch Oral Biol</source> <volume>39</volume>: <fpage>1035</fpage>–<lpage>1040</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004215-Chou1"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chou</surname><given-names>H-H</given-names></name>, <name name-style="western"><surname>Yumoto</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Davey</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Miyamoto</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells</article-title>. <source>Infection and Immunity</source> <volume>73</volume>: <fpage>5367</fpage>–<lpage>5378</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.73.9.5367-5378.2005" xlink:type="simple">10.1128/IAI.73.9.5367-5378.2005</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Hayashi4"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hayashi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Viereck</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hua</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Phinikaridou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Madrigal</surname><given-names>AG</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice</article-title>. <source>Atherosclerosis</source> <volume>215</volume>: <fpage>52</fpage>–<lpage>59</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.atherosclerosis.2010.12.009" xlink:type="simple">10.1016/j.atherosclerosis.2010.12.009</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Burns1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burns</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Bachrach</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Shapira</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Nussbaum</surname><given-names>G</given-names></name> (<year>2006</year>) <article-title>Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption</article-title>. <source>J Immunol</source> <volume>177</volume>: <fpage>8296</fpage>–<lpage>8300</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004215-Ukai1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ukai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yumoto</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gibson</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Genco</surname><given-names>CA</given-names></name> (<year>2008</year>) <article-title>Macrophage-Elicited Osteoclastogenesis in Response to Bacterial Stimulation Requires Toll-Like Receptor 2-Dependent Tumor Necrosis Factor-Alpha Production</article-title>. <source>Infection and Immunity</source> <volume>76</volume>: <fpage>812</fpage>–<lpage>819</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.01241-07" xlink:type="simple">10.1128/IAI.01241-07</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Coats4"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Coats</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Do</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Karimi-Naser</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Braham</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Darveau</surname><given-names>RP</given-names></name> (<year>2007</year>) <article-title>Antagonistic lipopolysaccharides block E. coli lipopolysaccharide function at human TLR4 via interaction with the human MD-2 lipopolysaccharide binding site</article-title>. <source>Cellular Microbiology</source> <volume>9</volume>: <fpage>1191</fpage>–<lpage>1202</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1462-5822.2006.00859.x" xlink:type="simple">10.1111/j.1462-5822.2006.00859.x</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Montminy1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Montminy</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>McGrath</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Walkowicz</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response</article-title>. <source>Nat Immunol</source> <volume>7</volume>: <fpage>1066</fpage>–<lpage>1073</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ni1386" xlink:type="simple">10.1038/ni1386</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Cigana1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cigana</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Curcurù</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Leone</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Ieranò</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lorè</surname><given-names>NI</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection</article-title>. <source>PLoS ONE</source> <volume>4</volume>: <fpage>e8439</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0008439" xlink:type="simple">10.1371/journal.pone.0008439</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Davis1"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davis</surname><given-names>BK</given-names></name>, <name name-style="western"><surname>Wen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ting</surname><given-names>JPY</given-names></name> (<year>2011</year>) <article-title>The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases</article-title>. <source>Annu Rev Immunol</source> <volume>29</volume>: <fpage>707</fpage>–<lpage>735</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1146/annurev-immunol-031210-101405" xlink:type="simple">10.1146/annurev-immunol-031210-101405</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Naiki1"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Naiki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sorrentino</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Michelsen</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Shimada</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis</article-title>. <source>The Journal of Immunology</source> <volume>181</volume>: <fpage>7176</fpage>–<lpage>7185</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004215-Michelsen1"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Michelsen</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>PK</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Yano</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E</article-title>. <source>Proc Natl Acad Sci USA</source> <volume>101</volume>: <fpage>10679</fpage>–<lpage>10684</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0403249101" xlink:type="simple">10.1073/pnas.0403249101</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Cole1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cole</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Mitra</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Monaco</surname><given-names>C</given-names></name> (<year>2010</year>) <article-title>Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets</article-title>. <source>Expert Rev Cardiovasc Ther</source> <volume>8</volume>: <fpage>1619</fpage>–<lpage>1635</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1586/erc.10.149" xlink:type="simple">10.1586/erc.10.149</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Leon1"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leon</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Tory</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sivak</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Wasan</surname><given-names>KM</given-names></name> (<year>2008</year>) <article-title>Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases</article-title>. <source>Pharm Res</source> <volume>25</volume>: <fpage>1751</fpage>–<lpage>1761</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s11095-008-9571-x" xlink:type="simple">10.1007/s11095-008-9571-x</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Carrion1"><label>64</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carrion</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Scisci</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Miles</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Sabino</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Zeituni</surname><given-names>AE</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential</article-title>. <source>The Journal of Immunology</source> <volume>189</volume>: <fpage>3178</fpage>–<lpage>3187</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.1201053" xlink:type="simple">10.4049/jimmunol.1201053</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Wang1"><label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shakhatreh</surname><given-names>M-AK</given-names></name>, <name name-style="western"><surname>James</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nishiyama</surname><given-names>S-I</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Fimbrial proteins of porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages</article-title>. <source>J Immunol</source> <volume>179</volume>: <fpage>2349</fpage>–<lpage>2358</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004215-Amer1"><label>66</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Amer</surname><given-names>AO</given-names></name>, <name name-style="western"><surname>Byrne</surname><given-names>BG</given-names></name>, <name name-style="western"><surname>Swanson</surname><given-names>MS</given-names></name> (<year>2005</year>) <article-title>Macrophages rapidly transfer pathogens from lipid raft vacuoles to autophagosomes</article-title>. <source>Autophagy</source> <volume>1</volume>: <fpage>53</fpage>–<lpage>58</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004215-Simons1"><label>67</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Simons</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gruenberg</surname><given-names>J</given-names></name> (<year>2000</year>) <article-title>Jamming the endosomal system: lipid rafts and lysosomal storage disease</article-title>. <source>Trends Cell Biol</source> <volume>10</volume>: <fpage>459</fpage>–<lpage>462</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004215-Gibson2"><label>68</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gibson</surname><given-names>FC</given-names><suffix>III</suffix></name>, <name name-style="western"><surname>Genco</surname><given-names>CA</given-names></name> (<year>2007</year>) <article-title>Porphyromonas gingivalis Mediated Periodontal Disease and Atheroscerlosis: Disparate Disease with Commonalities in Pathogenesis Through TLRs</article-title>. <source>Current Pharmaceutical Design</source> <volume>13</volume>: <fpage>3665</fpage>–<lpage>3675</lpage>.</mixed-citation>
</ref>
<ref id="ppat.1004215-Hajishengallis1"><label>69</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hajishengallis</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Payne</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Hashim</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jotwani</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement</article-title>. <source>Cell Host Microbe</source> <volume>10</volume>: <fpage>497</fpage>–<lpage>506</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.chom.2011.10.006" xlink:type="simple">10.1016/j.chom.2011.10.006</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Dinarello1"><label>70</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></name> (<year>2011</year>) <article-title>A clinical perspective of IL-1β as the gatekeeper of inflammation</article-title>. <source>Eur J Immunol</source> <volume>41</volume>: <fpage>1203</fpage>–<lpage>1217</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/eji.201141550" xlink:type="simple">10.1002/eji.201141550</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Tabas1"><label>71</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tabas</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Glass</surname><given-names>CK</given-names></name> (<year>2013</year>) <article-title>Anti-inflammatory therapy in chronic disease: challenges and opportunities</article-title>. <source>Science</source> <volume>339</volume>: <fpage>166</fpage>–<lpage>172</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1230720" xlink:type="simple">10.1126/science.1230720</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Ridker1"><label>72</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ridker</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Thuren</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zalewski</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Libby</surname><given-names>P</given-names></name> (<year>2011</year>) <article-title>Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)</article-title>. <source>Am Heart J</source> <volume>162</volume>: <fpage>597</fpage>–<lpage>605</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ahj.2011.06.012" xlink:type="simple">10.1016/j.ahj.2011.06.012</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Takahashi1"><label>73</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Takahashi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Davey</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yumoto</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gibson</surname><given-names>FC</given-names><suffix>III</suffix></name>, <name name-style="western"><surname>Genco</surname><given-names>CA</given-names></name> (<year>2006</year>) <article-title>Fimbria-dependent activation of pro-inflammatory molecules in Porphyromonas gingivalis infected human aortic endothelial cells</article-title>. <source>Cellular Microbiology</source> <volume>8</volume>: <fpage>738</fpage>–<lpage>757</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1462-5822.2005.00661.x" xlink:type="simple">10.1111/j.1462-5822.2005.00661.x</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Coats5"><label>74</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Coats</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>To</surname><given-names>TT</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Braham</surname><given-names>PH</given-names></name>, <name name-style="western"><surname>Darveau</surname><given-names>RP</given-names></name> (<year>2009</year>) <article-title>Porphyromonas gingivalis resistance to polymyxin B is determined by the lipid A 4′-phosphatase, PGN_0524</article-title>. <source>Int J Oral Sci</source> <volume>1</volume>: <fpage>126</fpage>–<lpage>135</lpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4248/IJOS.09062" xlink:type="simple">10.4248/IJOS.09062</ext-link></comment></mixed-citation>
</ref>
<ref id="ppat.1004215-Madrigal1"><label>75</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Madrigal</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Barth</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Papadopoulos</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Genco</surname><given-names>CA</given-names></name> (<year>2012</year>) <article-title>Pathogen-Mediated Proteolysis of the Cell Death Regulator RIPK1 and the Host Defense Modulator RIPK2 in Human Aortic Endothelial Cells</article-title>. <source>PLoS Pathog</source> <volume>8</volume>: <fpage>e1002723</fpage> <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1002723.g011" xlink:type="simple">10.1371/journal.ppat.1002723.g011</ext-link></comment></mixed-citation>
</ref>
</ref-list></back>
</article>